Editor: NOEL GONZÁLEZ GOTERA Número 164 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 291114 – 051214 Foto: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.

ARTÍCULOS CIENTÍFICOS

Publicaciones incluidas en PubMED durante el período comprendido entre el 29 de noviembre y el 5 de diciembre de 2014. Con “vaccin*” en título: 256 artículos recuperados.

Vacunas meningococo (Neisseria meningitidis)

13. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass with the meningococcal conjugate , MenAfriVac.

Kristiansen PA, Ba A, Ouédraogo AS, Sanou I, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Saga I, Misegades L, Clark TA, Préziosi MP, Caugant DA.

BMC Infect Dis. 2014 Dec 4;14(1):663. [Epub ahead of print]

PMID: 25472422 [PubMed - as supplied by publisher]

Related citations

Select item 25472209

54. Immunogenicity and Safety of Meningococcal C in Children and Adolescents Infected and Uninfected with Human Immunodeficiency Virus in Rio de Janeiro, Brazil.

Frota AC, Milagres LG, Harrison LH, Ferreira B, Barreto DM, Pereira GS, Cruz AC, Pereira-Manfro W, de Oliveira RH, Abreu TF, Hofer CB.

Pediatr Infect Dis J. 2014 Dec 3. [Epub ahead of print]

PMID: 25461473 [PubMed - as supplied by publisher]

Related citations

Select item 25461243

1

144. Immunogenicity of meningococcal quadrivalent (serogroup A, C, W135 and Y) tetanus conjugate vaccine: Systematic review and meta-analysis.

Pellegrino P, Perrone V, Radice S, Capuano A, Clementi E.

Pharmacol Res. 2014 Oct 30. pii: S1043-6618(14)00167-4. doi: 10.1016/j.phrs.2014.10.006. [Epub ahead of print] Review.

PMID: 25447792 [PubMed - as supplied by publisher]

Related citations

Select item 25447598

213. [Programming and implementation a meningitis vaccination campaign in Africa.]

Pérez-Manchón D.

Enferm Clin. 2014 Oct 24. pii: S1130-8621(14)00085-0. doi: 10.1016/j.enfcli.2014.06.002. [Epub ahead of print] Spanish. No abstract available.

PMID: 25442122 [PubMed - as supplied by publisher]

Related citations

Select item 25441634

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

28. BALB/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL/6 mice but have equivalent protection.

Garcia-Pelayo MC, Bachy VS, Kaveh DA, Hogarth PJ.

Tuberculosis (Edinb). 2014 Nov 11. pii: S1472-9792(13)20294-5. doi: 10.1016/j.tube.2014.10.012. [Epub ahead of print]

PMID: 25467292 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25466778

94. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.

Pang Y, Kang W, Zhao A, Liu G, Du W, Xu M, Wang G, Zhao Y, Zheng S.

Vaccine. 2014 Nov 6. pii: S0264-410X(14)01405-4. doi: 10.1016/j.vaccine.2014.10.030. [Epub ahead of print]

PMID: 25454854 [PubMed - as supplied by publisher] 2

Related citations

Select item 25454853

125. Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous in mice.

Derrick SC, Yang A, Parra M, Kolibab K, Morris SL.

Vaccine. 2014 Nov 15. pii: S0264-410X(14)01516-3. doi: 10.1016/j.vaccine.2014.11.004. [Epub ahead of print]

PMID: 25448108 [PubMed - as supplied by publisher]

Related citations

Select item 25448107

126. BCG vaccination-induced long-lasting control of Mycobacterium correlates with the accumulation of a novel population of CD4+IL- 17+TNF+IL-2+ T cells.

Cruz A, Torrado E, Carmona J, Fraga AG, Costa P, Rodrigues F, Appelberg R, Correia-Neves M, Cooper AM, Saraiva M, Pedrosa J, Castro AG.

Vaccine. 2014 Nov 20. pii: S0264-410X(14)01537-0. doi: 10.1016/j.vaccine.2014.11.013. [Epub ahead of print]

PMID: 25448107 [PubMed - as supplied by publisher]

Related citations

Select item 25448106

Vacunas neumococo ( pneumoniae)

55. Nasopharyngeal carriage of Streptococcus pneumoniae in Romanian children before the introduction of the pneumococcal conjugated vaccination into the national immunization programme: a national, multi-centre, cross-sectional observational study.

Luminos M, Dorobat O, Jugulete G, Popescu GA, Florea D, Draganescu A, Cercel AS, Rafila A; on behalf of the of the SP5000 study group.

Int J Infect Dis. 2014 Oct 30;29C:169-173. doi: 10.1016/j.ijid.2014.08.020. [Epub ahead of print]

PMID: 25461243 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25460825

110. Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine. 3

Hirose TE, Maluf EM, Rodrigues CO.

J Pediatr (Rio J). 2014 Oct 16. pii: S0021-7557(14)00144-2. doi: 10.1016/j.jped.2014.07.002. [Epub ahead of print]

PMID: 25451210 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25451136

120. Identification of Proteins in Streptococcus pneumoniae by Reverse Vaccinology and Genetic Diversity of These Proteins in Clinical Isolates.

Argondizzo AP, da Mota FF, Pestana CP, Reis JN, de Miranda AB, Galler R, Medeiros MA.

Appl Biochem Biotechnol. 2014 Dec 2. [Epub ahead of print]

PMID: 25448632 [PubMed - as supplied by publisher]

Related citations

Select item 25448542

128. Impact of the pneumococcal conjugate on invasive pneumococcal disease in France, 2001-2012.

Lepoutre A, Varon E, Georges S, Dorléans F, Janoir C, Gutmann L, Lévy-Bruhl D; the Microbiologists of the Epibac; the ORP Networks.

Vaccine. 2014 Nov 20. pii: S0264-410X(14)01535-7. doi: 10.1016/j.vaccine.2014.11.011. [Epub ahead of print]

PMID: 25448105 [PubMed - as supplied by publisher]

Related citations

Select item 25448104

130. Comparison of the immunogenicity and safety of polysaccharide and protein-conjugated pneumococcal vaccines among the elderly aged 80 years or older in Japan: An open-labeled randomized study.

Namkoong H, Funatsu Y, Oishi K, Akeda Y, Hiraoka R, Takeshita K, Asami T, Yagi K, Kimizuka Y, Ishii M, Tasaka S, Suzuki Y, Iwata S, Betsuyaku T, Hasegawa N.

Vaccine. 2014 Nov 22. pii: S0264-410X(14)01562-X. doi: 10.1016/j.vaccine.2014.11.023. [Epub ahead of print]

PMID: 25448102 [PubMed - as supplied by publisher] Free Article

Related citations

4

Select item 25448101

143. Evaluation of antibody levels over 3years after 23-valent pneumococcal polysaccharide vaccination in patients with pulmonary diseases receiving steroids and immunosuppressive agents.

Akamatsu T, Inui N, Kusagaya H, Nakamura Y, Suda T, Chida K.

Clin Biochem. 2014 Nov 13. pii: S0009-9120(14)00747-4. doi: 10.1016/j.clinbiochem.2014.11.005. [Epub ahead of print]

PMID: 25448031 [PubMed - as supplied by publisher]

Related citations

Select item 25447792

169. Emergence of serogroup 15 Streptococcus pneumoniae of diverse genetic backgrounds following the introduction of pneumococcal conjugate vaccines in Hong Kong.

Liyanapathirana V, Nelson EA, Ang I, Subramanian R, Ma H, Ip M.

Diagn Microbiol Infect Dis. 2014 Oct 2. pii: S0732-8893(14)00408-8. doi: 10.1016/j.diagmicrobio.2014.09.028. [Epub ahead of print]

PMID: 25445117 [PubMed - as supplied by publisher]

Related citations

Select item 25444836

Vacunas fiebre tifoidea (Salmonella typhi)

207. Effectiveness of the Typhoid Vi Vaccine in Overseas Travelers from England.

Wagner KS, Freedman JL, Andrews NJ, Jones JA.

J Travel Med. 2014 Nov 30. doi: 10.1111/jtm.12178. [Epub ahead of print]

PMID: 25444695 [PubMed - as supplied by publisher]

Related citations

Select item 25444525

243. Specific and cross-reactive immune response to oral Salmonella Typhi and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.

Pakkanen SH, Kantele JM, Savolainen LE, Rombo L, Kantele A.

Vaccine. 2014 Nov 26. pii: S0264-410X(14)01569-2. doi: 10.1016/j.vaccine.2014.11.030. [Epub ahead of print]

PMID: 25433216

5

[PubMed - as supplied by publisher] Free Article

Related citations

Select item 25433189

Vacuna tuberculosis (Mycobacterium tuberculosis)

61. The present and future of tuberculosis .

Principi N, Esposito S.

Tuberculosis (Edinb). 2014 Oct 22. pii: S1472-9792(14)20570-1. doi: 10.1016/j.tube.2014.10.004. [Epub ahead of print] Review.

PMID: 25458613 [PubMed - as supplied by publisher]

Related citations

Select item 25458600

177. Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media.

Daly KA, Scott Giebink G, Lindgren BR, Knox J, Haggerty BJ, Nordin J, Goetz S, Ferrieri P.

Vaccine. 2014 Oct 30;32(51):6948-6955. doi: 10.1016/j.vaccine.2014.10.060. [Epub ahead of print]

PMID: 25444821 [PubMed - as supplied by publisher]

Related citations

Select item 25444820

240. Assessment of phagosomes infected with Mycobacterium tuberculosis as a vaccine candidate against tuberculosis.

Sharma A, Parihar P, Sharma J.

Indian J Exp Biol. 2014 Nov;52(11):1090-7.

PMID: 25434104 [PubMed - in process]

Related citations

Select item 25433619

246. TB vaccine development: where are we and why is it so difficult?

Wilkie ME, McShane H.

6

Thorax. 2014 Nov 28. pii: thoraxjnl-2014-205202. doi: 10.1136/thoraxjnl-2014-205202. [Epub ahead of print]

PMID: 25432943 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25432792

Vacuna tosferina (Bordetella pertussis)

85. for adults: Knowledge, attitudes, and vaccine receipt among adults with children in the household.

Suryadevara M, Bonville CA, Cibula DA, Valente M, Handel A, Domachowse JR, Domachowske JB.

Vaccine. 2014 Oct 25;32(51):7000-7004. doi: 10.1016/j.vaccine.2014.10.018. [Epub ahead of print]

PMID: 25454869 [PubMed - as supplied by publisher]

Related citations

Select item 25454867

195. What predicts postpartum pertussis booster vaccination? A controlled intervention trial.

Hayles EH, Cooper SC, Wood N, Sinn J, Skinner SR.

Vaccine. 2014 Nov 7. pii: S0264-410X(14)01464-9. doi: 10.1016/j.vaccine.2014.10.074. [Epub ahead of print]

PMID: 25444794 [PubMed - as supplied by publisher]

Related citations

Select item 25444793

Vacunas cólera (Vibrio cholerae)

7. Comparative Effectiveness of Different Strategies of Oral Cholera Vaccination in Bangladesh: A Modeling Study.

Dimitrov DT, Troeger C, Halloran ME, Longini IM, Chao DL.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3343. doi: 10.1371/journal.pntd.0003343. eCollection 2014 Dec.

PMID: 25473851 [PubMed - as supplied by publisher] Select item 25473675

7

231. Introducing cholera vaccination in Asia, Africa and Haiti: A meeting report.

Hall RH, Sack DA.

Vaccine. 2014 Nov 28. pii: S0264-410X(14)01570-9. doi: 10.1016/j.vaccine.2014.11.031. [Epub ahead of print]

PMID: 25437100 [PubMed - as supplied by publisher]

Related citations

Select item 25436508

Vacunas, otras

1. Natural and Vaccine-Mediated Immunity to Salmonella Typhimurium is Impaired by the Helminth Nippostrongylus brasiliensis.

Bobat S, Darby M, Mrdjen D, Cook C, Logan E, Auret J, Jones E, Schnoeller C, Flores- Langarica A, Ross EA, Vira A, López-Macías C, Henderson IR, Alexander J, Brombacher F, Horsnell WG, Cunningham AF.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3341. doi: 10.1371/journal.pntd.0003341. eCollection 2014 Dec.

PMID: 25474738 [PubMed - as supplied by publisher]

Select item 25474621 2.

Murine Anti-vaccinia Virus D8 Antibodies Target Different Epitopes and Differ in Their Ability to Block D8 Binding to CS-E.

Matho MH, de Val N, Miller GM, Brown J, Schlossman A, Meng X, Crotty S, Peters B, Xiang Y, Hsieh-Wilson LC, Ward AB, Zajonc DM.

PLoS Pathog. 2014 Dec 4;10(12):e1004495. doi: 10.1371/journal.ppat.1004495. eCollection 2014 Dec.

PMID: 25474621 [PubMed - as supplied by publisher]

Select item 25474576 3.

Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management.

Galabova G, Brunner S, Winsauer G, Juno C, Wanko B, Mairhofer A, Lührs P, Schneeberger A, von Bonin A, Mattner F, Schmidt W, Staffler G.

PLoS One. 2014 Dec 4;9(12):e114469. doi: 10.1371/journal.pone.0114469. eCollection 2014.

8

PMID: 25474576 [PubMed - as supplied by publisher]

Select item 25474384 4.

Knowledge, Attitudes, and Beliefs About Human Papillomavirus (HPV) Vaccination Among Puerto Rican Mothers and Daughters, 2010: A Qualitative Study.

Fernández ME, Le YC, Fernández-Espada N, Calo WA, Savas LS, Vélez C, Aragon AP, Colón-López V.

Prev Chronic Dis. 2014 Dec 4;11:E212. doi: 10.5888/pcd11.140171.

PMID: 25474384 [PubMed - as supplied by publisher]

Select item 25474286 5.

An interview with Margaret A Liu: the future of gene-based vaccines and immunotherapies, and other musings.

Liu MA.

Expert Rev Vaccines. 2014 Dec 4:1-3. [Epub ahead of print]

PMID: 25474286 [PubMed - as supplied by publisher]

Select item 25474206 6.

Reducing Campylobacter jejuni Colonization of Poultry via Vaccination.

Neal-McKinney JM, Samuelson DR, Eucker TP, Nissen MS, Crespo R, Konkel ME.

PLoS One. 2014 Dec 4;9(12):e114254. doi: 10.1371/journal.pone.0114254. eCollection 2014.

PMID: 25474206 [PubMed - as supplied by publisher]

Select item 25473851 7.

Comparative Effectiveness of Different Strategies of Oral Cholera Vaccination in Bangladesh: A Modeling Study.

Dimitrov DT, Troeger C, Halloran ME, Longini IM, Chao DL.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3343. doi: 10.1371/journal.pntd.0003343. eCollection 2014 Dec.

PMID:

9

25473851 [PubMed - as supplied by publisher]

Select item 25473675 8.

International community ramps up effort.

Mohammadi D.

Lancet. 2014 Nov 8;384(9955):1658-9. No abstract available.

PMID: 25473675 [PubMed - in process]

Related citations

Select item 25473375 9.

Pilot Study on Interferon-γ-producing T Cell Subsets after the Protective Vaccination with Radiation-attenuated Cercaria of Schistosoma japonicum in the Miniature Pig Model.

Abdel-Hafeez EH, Watanabe K, Kamei K, Kikuchi M, Chen H, Daniel B, Yu C, Hirayama K.

Trop Med Health. 2014 Dec;42(4):155-162. Epub 2014 Aug 23.

PMID: 25473375 [PubMed - as supplied by publisher]

Related citations

Select item 25473060 10.

Structure-function Analysis of Vaccinia Virus H7 protein Reveals a Novel Phosphoinositide Binding Fold Essential for Poxvirus Replication.

Kolli S, Meng X, Wu X, Shengjuler D, Cameron CE, Xiang Y, Deng J.

J Virol. 2014 Dec 3. pii: JVI.03073-14. [Epub ahead of print]

PMID: 25473060 [PubMed - as supplied by publisher]

Related citations

Select item 25473055 11.

10

Live-attenuated measles virus vaccine targets dendritic cells and macrophages in the muscle of non-human primates.

Rennick LJ, de Vries RD, Carsillo TJ, Lemon K, van Amerongen G, Ludlow M, Nguyen DT, Yüksel S, Verburgh RJ, Haddock P, McQuaid S, Duprex WP, de Swart RL.

J Virol. 2014 Dec 3. pii: JVI.02924-14. [Epub ahead of print]

PMID: 25473055 [PubMed - as supplied by publisher]

Related citations

Select item 25472756 12.

Chitosan-HPMC-blended microspheres as a vaccine carrier for the delivery of tetanus toxoid.

Arthanari S, Mani G, Peng MM, Jang HT.

Artif Cells Nanomed Biotechnol. 2014 Dec 4:1-7. [Epub ahead of print]

PMID: 25472756 [PubMed - as supplied by publisher]

Related citations

Select item 25472422 13.

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.

Kristiansen PA, Ba A, Ouédraogo AS, Sanou I, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Saga I, Misegades L, Clark TA, Préziosi MP, Caugant DA.

BMC Infect Dis. 2014 Dec 4;14(1):663. [Epub ahead of print]

PMID: 25472422 [PubMed - as supplied by publisher]

Related citations

Select item 25472209 14.

160 strategic vaccination against bovine viral diarrhea (bvd), infectious bovine rhinotracheitis (ibr) and improves pregnancy rate in ftai protocols in nelore beef cows.

11

Souto LA, Maturana Filho M, Lemes KM, Torres FD, Madureira EH.

Reprod Fertil Dev. 2014 Dec;27(1):171. doi: 10.1071/RDv27n1Ab160.

PMID: 25472209 [PubMed - in process]

Related citations

Select item 25471858 15.

Positive results spur race for Ebola vaccine.

Callaway E.

Nature. 2014 Dec 4;516(7529):15-6. doi: 10.1038/516015a. No abstract available.

PMID: 25471858 [PubMed - in process]

Related citations

Select item 25471322 16.

Antibody and T cell responses associated with experimental human or vaccination show limited relationships.

Walker KM, Okitsu S, Porter DW, Duncan C, Amacker M, Pluschke G, Cavanagh DR, Hill AV, Todryk SM.

Immunology. 2014 Dec 3. doi: 10.1111/imm.12428. [Epub ahead of print]

PMID: 25471322 [PubMed - as supplied by publisher]

Related citations

Select item 25470757 17.

Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.

Farjah A, Owlia P, Siadat SD, Mousavi SF, Ardestani MS, Mohammadpour HK.

APMIS. 2014 Dec 3. doi: 10.1111/apm.12337. [Epub ahead of print]

PMID: 25470757

12

[PubMed - as supplied by publisher]

Related citations

Select item 25470194 18.

Vaccines: taking a shot at protection.

Weintraub K.

Nature. 2014 Dec 4;516(7529):S12-3. doi: 10.1038/516S12a. No abstract available.

PMID: 25470194 [PubMed - in process]

Related citations

Select item 25469375 19.

Global routine vaccination coverage, 2013¹.

[No authors listed]

Wkly Epidemiol Rec. 2014 Nov 21;89(47):517-22. English, French. No abstract available.

PMID: 25469375 [PubMed - in process]

Related citations

Select item 25468265 20.

Methodological and ethical issues in research using social media: a metamethod of Human Papillomavirus vaccine studies.

Gustafson DL, Woodworth CF.

BMC Med Res Methodol. 2014 Dec 2;14(1):127. [Epub ahead of print]

PMID: 25468265 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25468066 21.

13

Vaccine therapy for cytomegalovirus in the setting of allogeneic hematopoietic cell transplantation.

Kharfan-Dabaja MA, Nishihori T.

Expert Rev Vaccines. 2014 Dec 3:1-10. [Epub ahead of print]

PMID: 25468066 [PubMed - as supplied by publisher]

Related citations

Select item 25467991 22.

Establishment of an antibody avidity test to differentiate vaccinated cattle from those naturally infected with Mycoplasma bovis.

Han X, Khan FA, Zhu X, Zhang R, Mustafa R, Hu C, Chen Y, Chen H, Guo A.

Vet J. 2014 Nov 7. pii: S1090-0233(14)00445-6. doi: 10.1016/j.tvjl.2014.10.032. [Epub ahead of print]

PMID: 25467991 [PubMed - as supplied by publisher]

Related citations

Select item 25467890 23.

A Neospora caninum vaccine using recombinant proteins fails to prevent foetal infection in pregnant cattle after experimental intravenous challenge.

Hecker YP, Cóceres V, Wilkowsky SE, Jaramillo Ortiz JM, Morrell EL, Verna AE, Ganuza A, Cano DB, Lischinsky L, Angel SO, Zamorano P, Odeón AC, Leunda MR, Campero CM, Morein B, Moore DP.

Vet Immunol Immunopathol. 2014 Nov 8;162(3-4):142-153. doi: 10.1016/j.vetimm.2014.11.001. [Epub ahead of print]

PMID: 25467890 [PubMed - as supplied by publisher]

Related citations

Select item 25467837 24.

Production of a novel multi-epitope for cancer immunotherapy in TC-1 tumor-bearing mice.

14

Nezafat N, Sadraeian M, Rahbar MR, Khoshnoud MJ, Mohkam M, Gholami A, Banihashemi M, Ghasemi Y.

Biologicals. 2014 Nov 29. pii: S1045-1056(14)00114-6. doi: 10.1016/j.biologicals.2014.11.001. [Epub ahead of print]

PMID: 25467837 [PubMed - as supplied by publisher]

Related citations

Select item 25467734 25.

Dendritic cell-based vaccine research against cancer.

Mody N, Dubey S, Sharma R, Agrawal U, Vyas SP.

Expert Rev Clin Immunol. 2014 Dec 3:1-20. [Epub ahead of print]

PMID: 25467734 [PubMed - as supplied by publisher]

Related citations

Select item 25467593 26.

Is Canada patent deal obstructing Ebola vaccine development?

Attaran A, Nickerson JW.

Lancet. 2014 Nov 19;384(9958):e61. doi: 10.1016/S0140-6736(14)62044-4. [Epub ahead of print] No abstract available.

PMID: 25467593 [PubMed - as supplied by publisher]

Related citations

Select item 25467571 27.

Ebola: should we consider influenza vaccination?

Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y.

Lancet. 2014 Nov 19. pii: S0140-6736(14)62226-1. doi: 10.1016/S0140- 6736(14)62226-1. [Epub ahead of print] No abstract available.

PMID:

15

25467571 [PubMed - as supplied by publisher]

Related citations

Select item 25467292 28.

BALB/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL/6 mice but have equivalent protection.

Garcia-Pelayo MC, Bachy VS, Kaveh DA, Hogarth PJ.

Tuberculosis (Edinb). 2014 Nov 11. pii: S1472-9792(13)20294-5. doi: 10.1016/j.tube.2014.10.012. [Epub ahead of print]

PMID: 25467292 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25466778 29.

Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.

Tanner R, Kakalacheva K, Miller E, Pathan AA, Chalk R, Sander CR, Scriba T, Tameris M, Hawkridge T, Mahomed H, Hussey G, Hanekom W, Checkley A, McShane H, Fletcher HA.

BMC Infect Dis. 2014 Dec 3;14(1):660. [Epub ahead of print]

PMID: 25466778 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25466762 30.

Antibody response of cattle to vaccination with commercial modified live vaccines in Guatemala.

Gilbert A, Greenberg L, Moran D, Alvarez D, Alvarado M, Garcia DL, Peruski L.

Prev Vet Med. 2014 Oct 25. pii: S0167-5877(14)00351-1. doi: 10.1016/j.prevetmed.2014.10.011. [Epub ahead of print]

PMID: 25466762 [PubMed - as supplied by publisher] 16

Related citations

Select item 25466585 31.

Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment.

Vasaturo A, Verdoes M, de Vries J, Torensma R, Figdor CG.

Immunobiology. 2014 Nov 15. pii: S0171-2985(14)00232-0. doi: 10.1016/j.imbio.2014.11.007. [Epub ahead of print] Review.

PMID: 25466585 [PubMed - as supplied by publisher]

Related citations

Select item 25466268 32.

Uniform-sized water-in-oil vaccine formulations enhance immune response against Newcastle disease and avian influenza in chickens.

Liu Y, Wang L, Zhang Y, Zhang W, Chen X, Yang T, Wang Z, Ma G.

Int Immunopharmacol. 2014 Oct 23;23(2):603-608. doi: 10.1016/j.intimp.2014.10.011. [Epub ahead of print]

PMID: 25466268 [PubMed - as supplied by publisher]

Related citations

Select item 25465848 33.

Frequent Vaccination Missed Opportunities at Primary Care Encounters Contribute to Underimmunization.

Fu LY, Zook K, Gingold J, Gillespie CW, Briccetti C, Cora-Bramble D, Joseph JG, Moon RY.

J Pediatr. 2014 Oct 30. pii: S0022-3476(14)01033-6. doi: 10.1016/j.jpeds.2014.10.066. [Epub ahead of print]

PMID: 25465848 [PubMed - as supplied by publisher]

Related citations

17

Select item 25465442 34.

CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.

Rosalia RA, Cruz LJ, van Duikeren S, Tromp AT, Silva AL, Jiskoot W, de Gruijl T, Löwik C, Oostendorp J, van der Burg SH, Ossendorp F.

Biomaterials. 2014 Nov 26. pii: S0142-9612(14)01117-X. doi: 10.1016/j.biomaterials.2014.10.053. [Epub ahead of print]

PMID: 25465442 [PubMed - as supplied by publisher]

Related citations

Select item 25465382 35.

Plant-based vaccines against viruses.

Rybicki EP.

Virol J. 2014 Dec 3;11(1):205. [Epub ahead of print]

PMID: 25465382 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25465270 36.

Immune response to diphtheria booster vaccination.

Gozdas HT, Karabay O.

Am J Infect Control. 2014 Dec;42(12):1344. doi: 10.1016/j.ajic.2014.08.020. Epub 2014 Nov 25. No abstract available.

PMID: 25465270 [PubMed - in process]

Related citations

Select item 25465269 37.

Reply: Immune response to diphtheria booster vaccination.

18

Wiboonchutikul S, Manosuthi W.

Am J Infect Control. 2014 Dec;42(12):1344. doi: 10.1016/j.ajic.2014.09.002. Epub 2014 Nov 25. No abstract available.

PMID: 25465269 [PubMed - in process]

Related citations

Select item 25465179 38.

Characterization of two recent Japanese field isolates of canine distemper virus and examination of the avirulent strain utility as an .

Takenaka A, Yoneda M, Seki T, Uema M, Kooriyama T, Nishi T, Fujita K, Miura R, Tsukiyama-Kohara K, Sato H, Kai C.

Vet Microbiol. 2014 Oct 31;174(3-4):372-381. doi: 10.1016/j.vetmic.2014.10.024. [Epub ahead of print]

PMID: 25465179 [PubMed - as supplied by publisher]

Related citations

Select item 25464971 39.

Intussusception is associated with the detection of adenovirus C, enterovirus B and rotavirus in a rotavirus vaccinated population.

Minney-Smith CA, Levy A, Hodge M, Jacoby P, Williams SH, Carcione D, Roczo-Farkas S, Kirkwood CD, Smith DW.

J Clin Virol. 2014 Nov 4;61(4):579-584. doi: 10.1016/j.jcv.2014.10.018. [Epub ahead of print]

PMID: 25464971 [PubMed - as supplied by publisher]

Related citations

Select item 25464822 40.

Vaccination of cattle only is sufficient to stop FMDV transmission in mixed populations of sheep and cattle.

Bravo DE Rueda C, Dekker A, Eblé PL, DE Jong MC.

19

Epidemiol Infect. 2014 Dec 3:1-8. [Epub ahead of print]

PMID: 25464822 [PubMed - as supplied by publisher]

Related citations

Select item 25464113 41.

An overview of bioinformatics tools for epitope prediction: implications on vaccine development.

Soria-Guerra RE, Nieto-Gomez R, Govea-Alonso DO, Rosales-Mendoza S.

J Biomed Inform. 2014 Nov 10. pii: S1532-0464(14)00233-0. doi: 10.1016/j.jbi.2014.11.003. [Epub ahead of print] Review.

PMID: 25464113 [PubMed - as supplied by publisher]

Related citations

Select item 25463626 42.

Missed Opportunity to Provide HPV Vaccine and Educate Adolescents: Rhode Island Middle and High School Students' Self-Reported HPV Vaccination, 2013 RI YRBS.

Oh J, Washburn T, Kim HH.

R I Med J (2013). 2014 Dec 2;97(12):35-8. No abstract available.

PMID: 25463626 [PubMed - in process]

Related citations

Select item 25463615 43.

Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ

Barkhouse DA, Faber M, Hooper DC.

Virology. 2014 Nov 19;474C:174-180. doi: 10.1016/j.virol.2014.10.025. [Epub ahead of print]

PMID: 25463615

20

[PubMed - as supplied by publisher]

Related citations

Select item 25463298 44.

Protective immunity of grass carp immunized with DNA vaccine encoding the vp7 gene of grass carp reovirus using carbon nanotubes as a carrier molecule.

Zhu B, Liu GL, Gong YX, Ling F, Wang GX.

Fish Shellfish Immunol. 2014 Nov 25. pii: S1050-4648(14)00452-5. doi: 10.1016/j.fsi.2014.11.026. [Epub ahead of print]

PMID: 25463298 [PubMed - as supplied by publisher]

Related citations

Select item 25462556 45.

Single-walled carbon nanotubes as delivery vehicles enhance the immunoprotective effects of a recombinant vaccine against Aeromonas hydrophila.

Gong YX, Zhu B, Liu GL, Liu L, Ling F, Wang GX, Xu XG.

Fish Shellfish Immunol. 2014 Nov 14;42(1):213-220. doi: 10.1016/j.fsi.2014.11.004. [Epub ahead of print]

PMID: 25462556 [PubMed - as supplied by publisher]

Related citations

Select item 25462463 46.

Protein encoded by ORF093 is an effective vaccine candidate for infectious spleen and kidney necrosis virus in Chinese perch Siniperca chuatsi.

Li N, Fu X, Guo H, Lin Q, Liu L, Zhang D, Fang X, Wu S.

Fish Shellfish Immunol. 2014 Oct 17;42(1):88-90. doi: 10.1016/j.fsi.2014.10.008. [Epub ahead of print]

PMID: 25462463 [PubMed - as supplied by publisher]

Related citations

21

Select item 25462454 47.

Effect of size and temperature at vaccination on immunization and protection conferred by a live attenuated Francisella noatunensis immersion vaccine in red hybrid tilapia.

Soto E, Brown N, Gardenfors ZO, Yount S, Revan F, Francis S, Kearney MT, Camus A.

Fish Shellfish Immunol. 2014 Oct 18;41(2):593-599. doi: 10.1016/j.fsi.2014.10.009. [Epub ahead of print]

PMID: 25462454 [PubMed - as supplied by publisher]

Related citations

Select item 25462347 48.

RAB1A promotes Vaccinia virus replication by facilitating the production of intracellular enveloped virions.

Pechenick Jowers T, Featherstone RJ, Reynolds DK, Brown HK, James J, Prescott A, Haga IR, Beard PM.

Virology. 2014 Nov 25;475C:66-73. doi: 10.1016/j.virol.2014.11.007. [Epub ahead of print]

PMID: 25462347 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25462346 49.

Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects.

Zhang E, Kosinska AD, Ma Z, Dietze KK, Xu Y, Meng Z, Zhang X, Wang J, Wang B, Dittmer U, Roggendorf M, Yang D, Lu M.

Virology. 2014 Nov 25;475C:56-65. doi: 10.1016/j.virol.2014.11.004. [Epub ahead of print]

PMID: 25462346 [PubMed - as supplied by publisher]

Related citations 22

Select item 25462180 50.

Estimating Effectiveness Using Routine Surveillance Data among Children Aged 6-59 Months for Five Consecutive Influenza Seasons.

Su WJ, Chan TC, Chuang PH, Liu YL, Lee PI, Liu MT, Chuang JH.

Int J Infect Dis. 2014 Nov 18. pii: S1201-9712(14)01699-3. doi: 10.1016/j.ijid.2014.11.011. [Epub ahead of print]

PMID: 25462180 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25461535 51.

Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.

Gauger PC, Loving CL, Khurana S, Lorusso A, Perez DR, Kehrli ME Jr, Roth JA, Golding H, Vincent AL.

Virology. 2014 Oct 28;471-473C:93-104. doi: 10.1016/j.virol.2014.10.003. [Epub ahead of print]

PMID: 25461535 [PubMed - as supplied by publisher]

Related citations

Select item 25461534 52.

HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques.

Thomas MA, Tuero I, Demberg T, Vargas-Inchaustegui DA, Musich T, Xiao P, Venzon D, LaBranche C, Montefiori DC, DiPasquale J, Reed SG, DeVico A, Fouts T, Lewis GK, Gallo RC, Robert-Guroff M.

Virology. 2014 Oct 28;471-473C:81-92. doi: 10.1016/j.virol.2014.10.001. [Epub ahead of print]

PMID: 25461534 [PubMed - as supplied by publisher]

Related citations

23

Select item 25461526 53.

Development of an improved live attenuated antigenic marker CSF vaccine strain candidate with an increased genetic stability.

,Donnell V, Gladue DP, Carlson J, Lu Z׳Holinka LG, Fernandez-Sainz I, Sanford B, O Risatti GR, Borca MV.

Virology. 2014 Oct 15;471-473C:13-18. doi: 10.1016/j.virol.2014.09.021. [Epub ahead of print]

PMID: 25461526 [PubMed - as supplied by publisher]

Related citations

Select item 25461473 54.

Immunogenicity and Safety of Meningococcal C Conjugate Vaccine in Children and Adolescents Infected and Uninfected with Human Immunodeficiency Virus in Rio de Janeiro, Brazil.

Frota AC, Milagres LG, Harrison LH, Ferreira B, Barreto DM, Pereira GS, Cruz AC, Pereira-Manfro W, de Oliveira RH, Abreu TF, Hofer CB.

Pediatr Infect Dis J. 2014 Dec 3. [Epub ahead of print]

PMID: 25461473 [PubMed - as supplied by publisher]

Related citations

Select item 25461243 55.

Nasopharyngeal carriage of Streptococcus pneumoniae in Romanian children before the introduction of the pneumococcal conjugated vaccination into the national immunization programme: a national, multi-centre, cross-sectional observational study.

Luminos M, Dorobat O, Jugulete G, Popescu GA, Florea D, Draganescu A, Cercel AS, Rafila A; on behalf of the of the SP5000 study group.

Int J Infect Dis. 2014 Oct 30;29C:169-173. doi: 10.1016/j.ijid.2014.08.020. [Epub ahead of print]

PMID: 25461243 [PubMed - as supplied by publisher] Free Article

24

Related citations

Select item 25460825 56.

Strain diversity plays no major role in the varying efficacy of rotavirus vaccines: An overview.

Velasquez DE, Parashar UD, Jiang B.

Infect Genet Evol. 2014 Dec;28:561-71. doi: 10.1016/j.meegid.2014.10.008. Epub 2014 Oct 16.

PMID: 25460825 [PubMed - in process]

Related citations

Select item 25459586 57.

Drug and Vaccine Allergy.

Kelso JM.

Immunol Allergy Clin North Am. 2015 Feb;35(1):221-230. doi: 10.1016/j.iac.2014.09.013. Epub 2014 Nov 21. Review.

PMID: 25459586 [PubMed - as supplied by publisher]

Related citations

Select item 25459531 58.

Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant.

Murugappan S, Frijlink HW, Petrovsky N, Hinrichs WL.

Eur J Pharm Sci. 2014 Oct 20;66C:118-122. doi: 10.1016/j.ejps.2014.10.008. [Epub ahead of print]

PMID: 25459531 [PubMed - as supplied by publisher]

Related citations

Select item 25459227 59.

25

Virus-like particle & nano-particle vaccines Session 7: Respiratory.

Skibinski D.

Hum Vaccin Immunother. 2014 Dec 2:0. [Epub ahead of print] No abstract available.

PMID: 25459227 [PubMed - as supplied by publisher]

Related citations

Select item 25458914 60.

Virus-like Particle and Nano-Particle Vaccines 2014 - Session 10 Technology.

Effio CL, Hubbuch J.

Hum Vaccin Immunother. 2014 Nov 1:0. [Epub ahead of print]

PMID: 25458914 [PubMed - as supplied by publisher]

Related citations

Select item 25458613 61.

The present and future of tuberculosis vaccinations.

Principi N, Esposito S.

Tuberculosis (Edinb). 2014 Oct 22. pii: S1472-9792(14)20570-1. doi: 10.1016/j.tube.2014.10.004. [Epub ahead of print] Review.

PMID: 25458613 [PubMed - as supplied by publisher]

Related citations

Select item 25458600 62.

Virus-like particle & Nano-particle vaccines Session 6 review: Development & characterization.

Rutkowska D.

Hum Vaccin Immunother. 2014 Dec 2:0. [Epub ahead of print] No abstract available.

PMID: 26

25458600 [PubMed - as supplied by publisher]

Related citations

Select item 25458074 63.

Rabies vaccination among migrant workers in Thailand.

Joob B, Wiwanitkit V.

Travel Med Infect Dis. 2014 Oct 13;12(6PA):687. doi: 10.1016/j.tmaid.2014.10.001. [Epub ahead of print] No abstract available.

PMID: 25458074 [PubMed - as supplied by publisher]

Related citations

Select item 25457604 64.

Optimal vaccination strategies against vector-borne diseases.

Græsbøll K, Enøe C, Bødker R, Christiansen LE.

Spat Spatiotemporal Epidemiol. 2014 Oct;11:153-62. doi: 10.1016/j.sste.2014.07.005. Epub 2014 Jul 21.

PMID: 25457604 [PubMed - in process]

Related citations

Select item 25457512 65.

Mixed treatment comparison meta-analysis of porcine circovirus type 2 (PCV2) vaccines used in piglets. da Silva N, Carriquiry A, O'Neill K, Opriessnig T, O'Connor AM.

Prev Vet Med. 2014 Dec 1;117(3-4):413-424. doi: 10.1016/j.prevetmed.2014.10.006. Epub 2014 Oct 31. Review.

PMID: 25457512 [PubMed - as supplied by publisher]

Related citations

27

Select item 25457133 66.

Modeling the impact of vaccination control strategies on a foot and mouth disease outbreak in the Central United States.

McReynolds SW, Sanderson MW, Reeves A, Hill AE.

Prev Vet Med. 2014 Dec 1;117(3-4):487-504. doi: 10.1016/j.prevetmed.2014.10.005. Epub 2014 Oct 14.

PMID: 25457133 [PubMed - in process]

Related citations

Select item 25456809 67.

Factors affecting the uptake of vaccination by the elderly in Western society.

Eilers R, Krabbe PF, de Melker HE.

Prev Med. 2014 Oct 22;69C:224-234. doi: 10.1016/j.ypmed.2014.10.017. [Epub ahead of print] Review.

PMID: 25456809 [PubMed - as supplied by publisher]

Related citations

Select item 25456110 68.

Herpes Zoster in Children Vaccinated Against Varicella-Zoster Virus: Experience in our Hospital.

Caro-Gutiérrez D, López-Estebaranz JL, Naz-Villalba E, Ayala-Bernaldo de Quiros L.

Actas Dermosifiliogr. 2014 Nov 13. pii: S0001-7310(14)00450-5. doi: 10.1016/j.ad.2014.07.007. [Epub ahead of print] English, Spanish. No abstract available.

PMID: 25456110 [PubMed - as supplied by publisher]

Related citations

Select item 25455990 69.

28

Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies.

Darvishian M, Bijlsma MJ, Hak E, van den Heuvel ER.

Lancet Infect Dis. 2014 Dec;14(12):1228-39. doi: 10.1016/S1473-3099(14)70960-0. Epub 2014 Nov 6.

PMID: 25455990 [PubMed - in process]

Related citations

Select item 25455987 70.

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A : a randomised, double-blind phase 1/2a .

Kreijtz JH, Goeijenbier M, Moesker FM, van den Dries L, Goeijenbier S, De Gruyter HL, Lehmann MH, Mutsert Gd, van de Vijver DA, Volz A, Fouchier RA, van Gorp EC, Rimmelzwaan GF, Sutter G, Osterhaus AD.

Lancet Infect Dis. 2014 Dec;14(12):1196-207. doi: 10.1016/S1473-3099(14)70963-6. Epub 2014 Oct 30.

PMID: 25455987 [PubMed - in process]

Related citations

Select item 25455972 71.

Influenza vaccine effectiveness in elderly people.

Jackson ML.

Lancet Infect Dis. 2014 Dec;14(12):1169-70. doi: 10.1016/S1473-3099(14)70993-4. Epub 2014 Nov 6. No abstract available.

PMID: 25455972 [PubMed - in process]

Related citations

Select item 25455969 72.

Modern twist on a classic formula for influenza vaccination.

29

Höschler K, Thompson CI.

Lancet Infect Dis. 2014 Dec;14(12):1165-6. doi: 10.1016/S1473-3099(14)70996-X. Epub 2014 Oct 30. No abstract available.

PMID: 25455969 [PubMed - in process]

Related citations

Select item 25455657 73.

Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact.

Shen KY, Chang LS, Leng CH, Liu SJ.

Expert Rev Vaccines. 2014 Dec 2:1-12. [Epub ahead of print]

PMID: 25455657 [PubMed - as supplied by publisher]

Related citations

Select item 25455246 74.

Mosquito control might not bolster imperfect dengue vaccines.

Paul R, Sousa C, Sakuntabhai A, Devine G.

Lancet. 2014 Nov 15;384(9956):1747-8. doi: 10.1016/S0140-6736(14)62071-7. Epub 2014 Nov 14. No abstract available.

PMID: 25455246 [PubMed - in process]

Related citations

Select item 25455116 75.

Effect of decision support on missed opportunities for human papillomavirus vaccination.

Mayne SL, duRivage NE, Feemster KA, Localio AR, Grundmeier RW, Fiks AG.

Am J Prev Med. 2014 Dec;47(6):734-44. doi: 10.1016/j.amepre.2014.08.010. Epub 2014 Nov 18.

30

PMID: 25455116 [PubMed - in process]

Related citations

Select item 25455094 76.

A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β- amyloid antibody responses in mice with pre-existing virus specific memory.

Davtyan H, Ghochikyan A, Hovakimyan A, Davtyan A, Cadagan R, Marleau AM, Albrecht RA, García-Sastre A, Agadjanyan MG.

J Neuroimmunol. 2014 Oct 16;277(1-2):77-84. doi: 10.1016/j.jneuroim.2014.10.002. [Epub ahead of print]

PMID: 25455094 [PubMed - as supplied by publisher]

Related citations

Select item 25454883 77.

Varicella-zoster virus vaccination under the exogenous boosting hypothesis: Two ethical perspectives.

Luyten J, Ogunjimi B, Beutels P.

Vaccine. 2014 Oct 25;32(52):7175-7178. doi: 10.1016/j.vaccine.2014.10.015. [Epub ahead of print]

PMID: 25454883 [PubMed - as supplied by publisher]

Related citations

Select item 25454882 78.

Ethical considerations in post-market-approval monitoring and regulation of vaccines.

Thompson A, Komparic A, Smith MJ.

Vaccine. 2014 Oct 23;32(52):7171-7174. doi: 10.1016/j.vaccine.2014.10.016. [Epub ahead of print]

PMID: 25454882 [PubMed - as supplied by publisher] Free Article 31

Related citations

Select item 25454880 79.

What is the responsibility of national government with respect to vaccination?

Verweij MF, Houweling H.

Vaccine. 2014 Oct 22;32(52):7163-7166. doi: 10.1016/j.vaccine.2014.10.008. [Epub ahead of print]

PMID: 25454880 [PubMed - as supplied by publisher]

Related citations

Select item 25454879 80.

Vaccination ethics.

Viens AM, Dawson A.

Vaccine. 2014 Oct 29;32(52):7161-7162. doi: 10.1016/j.vaccine.2014.10.032. [Epub ahead of print] No abstract available.

PMID: 25454879 [PubMed - as supplied by publisher]

Related citations

Select item 25454878 81.

Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children.

Brady RC, Hu W, Houchin VG, Eder FS, Jackson KC, Hartel GF, Sawlwin DC, Albano FR, Greenberg M.

Vaccine. 2014 Oct 29;32(52):7141-7147. doi: 10.1016/j.vaccine.2014.10.024. [Epub ahead of print]

PMID: 25454878 [PubMed - as supplied by publisher]

Related citations

32

Select item 25454877 82.

Number needed to vaccinate to prevent hospitalizations of pregnant women due to inter-pandemic influenza in Sweden, 2003-2009.

Merk H, Nylén G, Kühlmann-Berenzon S, Linde A.

Vaccine. 2014 Oct 28;32(52):7135-7140. doi: 10.1016/j.vaccine.2014.10.027. [Epub ahead of print]

PMID: 25454877 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25454876 83.

Qualitative motivators and barriers to pandemic vs. seasonal influenza vaccination among healthcare workers: A content analysis.

Prematunge C, Corace K, McCarthy A, Nair RC, Roth V, Suh KN, Garber G.

Vaccine. 2014 Oct 28;32(52):7128-7134. doi: 10.1016/j.vaccine.2014.10.023. [Epub ahead of print]

PMID: 25454876 [PubMed - as supplied by publisher]

Related citations

Select item 25454875 84.

Determinants of influenza vaccination coverage rates among primary care patients in Krakow, Poland and the surrounding region.

Nessler K, Krztoń-Królewiecka A, Chmielowiec T, Jarczewska D, Windak A.

Vaccine. 2014 Oct 29;32(52):7122-7127. doi: 10.1016/j.vaccine.2014.10.026. [Epub ahead of print]

PMID: 25454875 [PubMed - as supplied by publisher]

Related citations

Select item 25454869 85.

33

Pertussis vaccine for adults: Knowledge, attitudes, and vaccine receipt among adults with children in the household.

Suryadevara M, Bonville CA, Cibula DA, Valente M, Handel A, Domachowse JR, Domachowske JB.

Vaccine. 2014 Oct 25;32(51):7000-7004. doi: 10.1016/j.vaccine.2014.10.018. [Epub ahead of print]

PMID: 25454869 [PubMed - as supplied by publisher]

Related citations

Select item 25454867 86.

The intention to get vaccinated against influenza and actual vaccination uptake of Dutch healthcare personnel.

Lehmann BA, Ruiter RA, Chapman G, Kok G.

Vaccine. 2014 Oct 28;32(51):6986-6991. doi: 10.1016/j.vaccine.2014.10.034. [Epub ahead of print]

PMID: 25454867 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25454866 87.

Investigation of immunity in sheep following footrot infection and vaccination.

Bhardwaj V, Dhungyel O, de Silva K, Whittington RJ.

Vaccine. 2014 Oct 29;32(51):6979-6985. doi: 10.1016/j.vaccine.2014.10.031. [Epub ahead of print]

PMID: 25454866 [PubMed - as supplied by publisher]

Related citations

Select item 25454864 88.

Are influenza-associated morbidity and mortality estimates for those ≥65 in statistical databases accurate, and an appropriate test of influenza vaccine effectiveness?

34

Thomas RE.

Vaccine. 2014 Oct 27;32(51):6884-6901. doi: 10.1016/j.vaccine.2014.08.090. [Epub ahead of print] Review.

PMID: 25454864 [PubMed - as supplied by publisher]

Related citations

Select item 25454861 89.

A novel approach for the generation of Salmonella Gallinarum ghosts and evaluation of their vaccine potential using a prime-booster immunization strategy.

Jawale CV, Lee JH.

Vaccine. 2014 Nov 28;32(50):6776-82. doi: 10.1016/j.vaccine.2014.10.012. Epub 2014 Oct 25.

PMID: 25454861 [PubMed - in process]

Related citations

Select item 25454859 90.

Parental attitudes and decision-making regarding MMR vaccination in an anthroposophic community in Sweden - A qualitative study.

Byström E, Lindstrand A, Likhite N, Butler R, Emmelin M.

Vaccine. 2014 Nov 28;32(50):6752-7. doi: 10.1016/j.vaccine.2014.10.011. Epub 2014 Oct 23.

PMID: 25454859 [PubMed - in process]

Related citations

Select item 25454857 91.

The mucosal immune system for vaccine development.

Lamichhane A, Azegami T, Kiyono H.

Vaccine. 2014 Oct 22;32(49):6711-6723. doi: 10.1016/j.vaccine.2014.08.089. [Epub ahead of print] Review.

35

PMID: 25454857 [PubMed - as supplied by publisher]

Related citations

Select item 25454856 92.

Why German farmers have their animals vaccinated against Bluetongue virus serotype 8: Results of a questionnaire survey.

Gethmann J, Zilow V, Probst C, Elbers AR, Conraths FJ.

Vaccine. 2014 Nov 8. pii: S0264-410X(14)01400-5. doi: 10.1016/j.vaccine.2014.10.025. [Epub ahead of print]

PMID: 25454856 [PubMed - as supplied by publisher]

Related citations

Select item 25454855 93.

Use of placebos in Phase 1 preventive HIV vaccine clinical trials.

Huang Y, Karuna ST, Janes H, Frahm N, Nason M, Edlefsen PT, Kublin JG, Corey L, McElrath MJ, Gilbert PB.

Vaccine. 2014 Oct 23. pii: S0264-410X(14)01378-4. doi: 10.1016/j.vaccine.2014.10.017. [Epub ahead of print]

PMID: 25454855 [PubMed - as supplied by publisher]

Related citations

Select item 25454854 94.

The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.

Pang Y, Kang W, Zhao A, Liu G, Du W, Xu M, Wang G, Zhao Y, Zheng S.

Vaccine. 2014 Nov 6. pii: S0264-410X(14)01405-4. doi: 10.1016/j.vaccine.2014.10.030. [Epub ahead of print]

PMID: 25454854 [PubMed - as supplied by publisher]

36

Related citations

Select item 25454853 95.

Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010- 2012.

Owusu JT, Prapasiri P, Ditsungnoen D, Leetongin G, Yoocharoen P, Rattanayot J, Olsen SJ, Muangchana C.

Vaccine. 2014 Nov 7. pii: S0264-410X(14)01404-2. doi: 10.1016/j.vaccine.2014.10.029. [Epub ahead of print]

PMID: 25454853 [PubMed - as supplied by publisher]

Related citations

Select item 25454810 96.

Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: Reality or fiction?

Basso B, Marini V.

Immunobiology. 2014 Oct 30. pii: S0171-2985(14)00194-6. doi: 10.1016/j.imbio.2014.10.003. [Epub ahead of print]

PMID: 25454810 [PubMed - as supplied by publisher]

Related citations

Select item 25454469 97.

Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.

Camussone CM, Pujato N, Renna MS, Veaute CM, Morein B, Marcipar IS, Calvinho LF.

Vet Immunol Immunopathol. 2014 Oct 14;162(3-4):96-107. doi: 10.1016/j.vetimm.2014.10.004. [Epub ahead of print]

PMID: 25454469 [PubMed - as supplied by publisher]

Related citations

37

Select item 25454089 98.

The long-term efficacy of Chinese hamster ovary cell derived after being used for 14-16 years in Chinese rural communities.

Wang F, Ma J, Hao Z, Zhang Z, Zhang X, Gao Z, Bi S, Shen L, Qiu F, Zhao Y.

Vaccine. 2014 Nov 29. pii: S0264-410X(14)01568-0. doi: 10.1016/j.vaccine.2014.11.029. [Epub ahead of print]

PMID: 25454089 [PubMed - as supplied by publisher]

Related citations

Select item 25454086 99.

Bovine herpesvirus-1: Evaluation of genetic diversity of subtypes derived from field strains of varied clinical syndromes and their relationship to vaccine strains.

Fulton RW, d'Offay JM, Eberle R, Moeller RB, Campen HV, O'Toole D, Chase C, Miller MM, Sprowls R, Nydam DV.

Vaccine. 2014 Nov 29. pii: S0264-410X(14)01572-2. doi: 10.1016/j.vaccine.2014.11.033. [Epub ahead of print]

PMID: 25454086 [PubMed - as supplied by publisher]

Related citations

Select item 25453974 100.

Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen- specific CD8+ T cell immune response.

Rahimian S, Kleinovink JW, Fransen MF, Mezzanotte L, Gold H, Wisse P, Overkleeft H, Amidi M, Jiskoot W, Löwik CW, Ossendorp F, Hennink WE.

Biomaterials. 2014 Oct 28;37C:469-477. doi: 10.1016/j.biomaterials.2014.10.043. [Epub ahead of print]

PMID: 25453974 [PubMed - as supplied by publisher]

Related citations

38

Select item 25453595 101.

Indications for the HPV vaccine in adolescents: A review of the literature.

Soares GR, Vieira RD, Pellizzer EP, Miyahara GI.

J Infect Public Health. 2014 Oct 13. pii: S1876-0341(14)00149-X. doi: 10.1016/j.jiph.2014.08.011. [Epub ahead of print] Review.

PMID: 25453595 [PubMed - as supplied by publisher]

Related citations

Select item 25453106 102.

Antibody-driven design of a human cytomegalovirus gHgLpUL128L that selectively elicits potent neutralizing antibodies.

Kabanova A, Perez L, Lilleri D, Marcandalli J, Agatic G, Becattini S, Preite S, Fuschillo D, Percivalle E, Sallusto F, Gerna G, Corti D, Lanzavecchia A.

Proc Natl Acad Sci U S A. 2014 Dec 1. pii: 201415310. [Epub ahead of print]

PMID: 25453106 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25452745 103.

Novel approaches to identify protective candidates.

Chia WN, Goh YS, Rénia L.

Front Microbiol. 2014 Nov 17;5:586. eCollection 2014. Review.

PMID: 25452745 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 25452681 104.

39

Evolutionary Analysis and Prediction of Peptide Vaccine Candidates for Foot-and- Mouth-Disease Virus Types A and O in Bangladesh.

Momtaz S, Rahman A, Sultana M, Hossain MA.

Evol Bioinform Online. 2014 Nov 3;10:187-196. eCollection 2014.

PMID: 25452681 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 25452596 105.

Disseminated persistent and fatal infection due to the vaccine strain (vOka) of varicella-zoster virus in an adult following stem cell transplantation.

Bhalla P, Forrest GN, Gershon M, Zhou Y, Chen J, LaRussa P, Steinberg S, Gershon AA.

Clin Infect Dis. 2014 Dec 1. pii: ciu970. [Epub ahead of print]

PMID: 25452596 [PubMed - as supplied by publisher]

Related citations

Select item 25452593 106.

Vaccines Against Malaria.

Ouattara A, Laurens MB.

Clin Infect Dis. 2014 Dec 1. pii: ciu954. [Epub ahead of print]

PMID: 25452593 [PubMed - as supplied by publisher]

Related citations

Select item 25452592 107.

Reduced Effectiveness Among Children Born During the Rotavirus Season: A Pooled Analysis of 5 Case-control Studies From the Americas.

Premkumar PS, Parashar UD, Gastanaduy PA, McCracken JP, de Oliveira LH, Payne DC, Patel MM, Tate JE, Lopman BA.

40

Clin Infect Dis. 2014 Dec 1. pii: ciu956. [Epub ahead of print]

PMID: 25452592 [PubMed - as supplied by publisher]

Related citations

Select item 25452148 108.

Comparison of and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development.

Jacob L, Leib R, Ollila HM, Bonvalet M, Adams CM, Mignot E.

Brain Behav Immun. 2014 Nov 15. pii: S0889-1591(14)00519-4. doi: 10.1016/j.bbi.2014.11.004. [Epub ahead of print]

PMID: 25452148 [PubMed - as supplied by publisher]

Related citations

Select item 25451327 109.

HPV vaccine acceptability in Africa: A systematic review.

Cunningham MS, Davison C, Aronson KJ.

Prev Med. 2014 Oct 24;69C:274-279. doi: 10.1016/j.ypmed.2014.08.035. [Epub ahead of print] Review.

PMID: 25451327 [PubMed - as supplied by publisher]

Related citations

Select item 25451210 110.

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine.

Hirose TE, Maluf EM, Rodrigues CO.

J Pediatr (Rio J). 2014 Oct 16. pii: S0021-7557(14)00144-2. doi: 10.1016/j.jped.2014.07.002. [Epub ahead of print]

PMID: 25451210

41

[PubMed - as supplied by publisher] Free Article

Related citations

Select item 25451136 111.

Formulation and stabilization of recombinant protein based virus-like particle vaccines.

Jain NK, Sahni N, Kumru OS, Joshi SB, Volkin DB, Russell Middaugh C.

Adv Drug Deliv Rev. 2014 Oct 24. pii: S0169-409X(14)00231-2. doi: 10.1016/j.addr.2014.10.023. [Epub ahead of print] Review.

PMID: 25451136 [PubMed - as supplied by publisher]

Related citations

Select item 25451106 112.

Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer.

Tiriveedhi V, Tucker N, Herndon J, Li L, Sturmoski M, Ellis M, Ma C, Naughton M, Lockhart AC, Gao F, Fleming T, Goedegebuure P, Mohanakumar T, Gillanders WE.

Clin Cancer Res. 2014 Dec 1;20(23):5964-75. doi: 10.1158/1078-0432.CCR-14-0059.

PMID: 25451106 [PubMed - in process]

Related citations

Select item 25450832 113.

Nanoparticle and polysaccharide conjugate: A potential candidate vaccine to improve immunological stimuli.

Devi KS, Sahoo B, Behera B, Maiti TK.

Int J Biol Macromol. 2014 Oct 23;72C:1254-1264. doi: 10.1016/j.ijbiomac.2014.10.026. [Epub ahead of print]

PMID: 25450832 [PubMed - as supplied by publisher]

42

Related citations

Select item 25450361 114.

Non-coding RNAs and heme oxygenase-1 in vaccinia virus infection.

Meseda CA, Srinivasan K, Wise J, Catalano J, Yamada KM, Dhawan S.

Biochem Biophys Res Commun. 2014 Oct 18;454(1):84-88. doi: 10.1016/j.bbrc.2014.10.035. [Epub ahead of print]

PMID: 25450361 [PubMed - as supplied by publisher]

Related citations

Select item 25450002 115.

An infected chicken kidney cell co-culture ELISpot for enhanced detection of T cell responses to avian influenza and vaccination.

Ruiz-Hernandez R, Peroval M, Boyd A, Balkissoon D, Staines K, Smith A, Butter C.

J Immunol Methods. 2014 Nov 7. pii: S0022-1759(14)00298-1. doi: 10.1016/j.jim.2014.10.012. [Epub ahead of print]

PMID: 25450002 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25449959 116.

Towards broadly protective polyvalent vaccines against hand, foot and mouth disease.

Liu Q, Tong X, Huang Z.

Microbes Infect. 2014 Nov 28. pii: S1286-4579(14)00300-1. doi: 10.1016/j.micinf.2014.11.004. [Epub ahead of print]

PMID: 25449959 [PubMed - as supplied by publisher]

Related citations

Select item 25449706 117.

43

Vaccination with outer membrane vesicles from Francisella noatunensis reduces development of francisellosis in a zebrafish model.

Brudal E, Lampe EO, Reubsaet L, Roos N, Hegna IK, Thrane IM, Koppang EO, Winther- Larsen HC.

Fish Shellfish Immunol. 2014 Oct 27;42(1):50-57. doi: 10.1016/j.fsi.2014.10.025. [Epub ahead of print]

PMID: 25449706 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25449428 118.

A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model.

Ahn E, Kim H, Han KT, Sin JI.

Cancer Lett. 2014 Oct 22. pii: S0304-3835(14)00618-1. doi: 10.1016/j.canlet.2014.10.019. [Epub ahead of print]

PMID: 25449428 [PubMed - as supplied by publisher]

Related citations

Select item 25448826 119.

Design and construction of a chimeric multi-epitope gene as an epitope-vaccine strategy against ALV-J.

Xu Q, Ma X, Wang F, Li H, Xiao Y, Zhao X.

Protein Expr Purif. 2015 Feb;106:18-24. doi: 10.1016/j.pep.2014.10.007. Epub 2014 Oct 24.

PMID: 25448826 [PubMed - in process]

Related citations

Select item 25448632 120.

Identification of Proteins in Streptococcus pneumoniae by Reverse Vaccinology and Genetic Diversity of These Proteins in Clinical Isolates. 44

Argondizzo AP, da Mota FF, Pestana CP, Reis JN, de Miranda AB, Galler R, Medeiros MA.

Appl Biochem Biotechnol. 2014 Dec 2. [Epub ahead of print]

PMID: 25448632 [PubMed - as supplied by publisher]

Related citations

Select item 25448542 121.

Development of a Thermostable Microneedle Patch for Influenza Vaccination.

Mistilis MJ, Bommarius AS, Prausnitz MR.

J Pharm Sci. 2014 Dec 1. doi: 10.1002/jps.24283. [Epub ahead of print]

PMID: 25448542 [PubMed - as supplied by publisher]

Related citations

Select item 25448355 122.

A 78 KDa host cell invasion protein of Neospora caninum as a potential vaccine candidate.

Lv Q, Xing S, Gong P, Chang L, Bian Z, Wang L, Zhang X, Li J.

Exp Parasitol. 2014 Nov 4. pii: S0014-4894(14)00230-6. doi: 10.1016/j.exppara.2014.10.006. [Epub ahead of print]

PMID: 25448355 [PubMed - as supplied by publisher]

Related citations

Select item 25448128 123.

[Spotted fever and the invention of its serodiagnosis and vaccination in the Austro- Hungarian army in World War I.]

Flamm H.

Wien Med Wochenschr. 2014 Dec 2. [Epub ahead of print] German.

PMID: 25448128

45

[PubMed - as supplied by publisher]

Related citations

Select item 25448109 124.

Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in Cuba.

Resik S, Tejeda A, Mach O, Fonseca M, Diaz M, Alemany N, Garcia G, Hung LH, Martinez Y, Sutter R.

Vaccine. 2014 Nov 22. pii: S0264-410X(14)01564-3. doi: 10.1016/j.vaccine.2014.11.025. [Epub ahead of print]

PMID: 25448109 [PubMed - as supplied by publisher]

Related citations

Select item 25448108 125.

Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice.

Derrick SC, Yang A, Parra M, Kolibab K, Morris SL.

Vaccine. 2014 Nov 15. pii: S0264-410X(14)01516-3. doi: 10.1016/j.vaccine.2014.11.004. [Epub ahead of print]

PMID: 25448108 [PubMed - as supplied by publisher]

Related citations

Select item 25448107 126.

BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL- 17+TNF+IL-2+ T cells.

Cruz A, Torrado E, Carmona J, Fraga AG, Costa P, Rodrigues F, Appelberg R, Correia- Neves M, Cooper AM, Saraiva M, Pedrosa J, Castro AG.

Vaccine. 2014 Nov 20. pii: S0264-410X(14)01537-0. doi: 10.1016/j.vaccine.2014.11.013. [Epub ahead of print]

PMID: 25448107 [PubMed - as supplied by publisher] 46

Related citations

Select item 25448106 127.

Development of a Salmonella cross-protective vaccine for food animal production systems.

Heithoff DM, House JK, Thomson PC, Mahan MJ.

Vaccine. 2014 Nov 20. pii: S0264-410X(14)01536-9. doi: 10.1016/j.vaccine.2014.11.012. [Epub ahead of print]

PMID: 25448106 [PubMed - as supplied by publisher]

Related citations

Select item 25448105 128.

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.

Lepoutre A, Varon E, Georges S, Dorléans F, Janoir C, Gutmann L, Lévy-Bruhl D; the Microbiologists of the Epibac; the ORP Networks.

Vaccine. 2014 Nov 20. pii: S0264-410X(14)01535-7. doi: 10.1016/j.vaccine.2014.11.011. [Epub ahead of print]

PMID: 25448105 [PubMed - as supplied by publisher]

Related citations

Select item 25448104 129.

Development of a subunit vaccine containing recombinant Riemerella anatipestifer outer membrane protein A and CpG ODN adjuvant.

Chu CY, Liu CH, Liou JJ, Lee JW, Cheng LT.

Vaccine. 2014 Nov 18. pii: S0264-410X(14)01534-5. doi: 10.1016/j.vaccine.2014.11.010. [Epub ahead of print]

PMID: 25448104 [PubMed - as supplied by publisher]

Related citations

47

Select item 25448102 130.

Comparison of the immunogenicity and safety of polysaccharide and protein- conjugated pneumococcal vaccines among the elderly aged 80 years or older in Japan: An open-labeled randomized study.

Namkoong H, Funatsu Y, Oishi K, Akeda Y, Hiraoka R, Takeshita K, Asami T, Yagi K, Kimizuka Y, Ishii M, Tasaka S, Suzuki Y, Iwata S, Betsuyaku T, Hasegawa N.

Vaccine. 2014 Nov 22. pii: S0264-410X(14)01562-X. doi: 10.1016/j.vaccine.2014.11.023. [Epub ahead of print]

PMID: 25448102 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25448101 131.

The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae.

Nerome K, Sugita S, Kuroda K, Hirose T, Matsuda S, Majima K, Kawasaki K, Shibata T, Poetri ON, Soejoedono RD, Mayasari NL, Agungpriyono S, Nerome R.

Vaccine. 2014 Nov 18. pii: S0264-410X(14)01533-3. doi: 10.1016/j.vaccine.2014.11.009. [Epub ahead of print]

PMID: 25448101 [PubMed - as supplied by publisher]

Related citations

Select item 25448100 132.

Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine.

Carter DM, Bloom CE, Kirchenbaum GA, Tsvetnitsky V, Isakova-Sivak I, Rudenko L, Ross TM.

Vaccine. 2014 Nov 18. pii: S0264-410X(14)01532-1. doi: 10.1016/j.vaccine.2014.11.008. [Epub ahead of print]

PMID: 25448100 [PubMed - as supplied by publisher]

Related citations 48

Select item 25448099 133.

A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.

Hu W, Zhang H, Han Q, Li L, Chen Y, Xia N, Chen Z, Shu Y, Xu K, Sun B.

Vaccine. 2014 Nov 18. pii: S0264-410X(14)01531-X. doi: 10.1016/j.vaccine.2014.11.007. [Epub ahead of print]

PMID: 25448099 [PubMed - as supplied by publisher]

Related citations

Select item 25448098 134.

Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008-2014.

Rodgers L, Pabst LJ, Chaves SS.

Vaccine. 2014 Nov 17. pii: S0264-410X(14)01530-8. doi: 10.1016/j.vaccine.2014.11.006. [Epub ahead of print]

PMID: 25448098 [PubMed - as supplied by publisher]

Related citations

Select item 25448097 135.

Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: A test-negative study.

Lytras T, Kossyvakis A, Melidou A, Exindari M, Gioula G, Pogka V, Malisiovas N, Mentis A.

Vaccine. 2014 Nov 18. pii: S0264-410X(14)01529-1. doi: 10.1016/j.vaccine.2014.11.005. [Epub ahead of print]

PMID: 25448097 [PubMed - as supplied by publisher]

Related citations

Select item 25448096 136.

49

The need for a multi-disciplinary perspective on and acceptance.

Poland CM, Brunson EK.

Vaccine. 2014 Nov 21. pii: S0264-410X(14)01547-3. doi: 10.1016/j.vaccine.2014.11.022. [Epub ahead of print] No abstract available.

PMID: 25448096 [PubMed - as supplied by publisher]

Related citations

Select item 25448095 137.

Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls.

Perkins RB, Zisblatt L, Legler A, Trucks E, Hanchate A, Gorin SS.

Vaccine. 2014 Nov 24. pii: S0264-410X(14)01546-1. doi: 10.1016/j.vaccine.2014.11.021. [Epub ahead of print]

PMID: 25448095 [PubMed - as supplied by publisher]

Related citations

Select item 25448094 138.

Development of a DNA vaccine for chicken infectious anemia and its immunogenicity studies using high mobility group box 1 protein as a novel immunoadjuvant indicated induction of promising protective immune responses.

Sawant PM, Dhama K, Rawool DB, Wani MY, Tiwari R, Singh SD, Singh RK.

Vaccine. 2014 Nov 21. pii: S0264-410X(14)01545-X. doi: 10.1016/j.vaccine.2014.11.020. [Epub ahead of print]

PMID: 25448094 [PubMed - as supplied by publisher]

Related citations

Select item 25448093 139.

Understanding influenza vaccine protection in the community: An assessment of the 2013 influenza season in Victoria, Australia.

50

Carville KS, Grant KA, Sullivan SG, Fielding JE, Lane CR, Franklin L, Druce J, Kelly HA.

Vaccine. 2014 Nov 22. pii: S0264-410X(14)01544-8. doi: 10.1016/j.vaccine.2014.11.019. [Epub ahead of print]

PMID: 25448093 [PubMed - as supplied by publisher]

Related citations

Select item 25448092 140.

Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial.

Langley JM, Frenette L, Jeanfreau R, Halperin SA, Kyle M, Chu L, McNeil S, Dramé M, Moris P, Fries L, Vaughn DW.

Vaccine. 2014 Nov 21. pii: S0264-410X(14)01543-6. doi: 10.1016/j.vaccine.2014.11.018. [Epub ahead of print]

PMID: 25448092 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25448091 141.

Vaccine schedule compliance among very low birth weight infants in Lima, Peru.

Ochoa TJ, Zea-Vera A, Bautista R, Davila C, Salazar JA, Bazán C, López L, Ecker L.

Vaccine. 2014 Nov 21. pii: S0264-410X(14)01539-4. doi: 10.1016/j.vaccine.2014.11.014. [Epub ahead of print]

PMID: 25448091 [PubMed - as supplied by publisher]

Related citations

Select item 25448090 142.

Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.

Shimizu H.

51

Vaccine. 2014 Nov 21. pii: S0264-410X(14)01540-0. doi: 10.1016/j.vaccine.2014.11.015. [Epub ahead of print] Review.

PMID: 25448090 [PubMed - as supplied by publisher]

Related citations

Select item 25448031 143.

Evaluation of antibody levels over 3years after 23-valent pneumococcal polysaccharide vaccination in patients with pulmonary diseases receiving steroids and immunosuppressive agents.

Akamatsu T, Inui N, Kusagaya H, Nakamura Y, Suda T, Chida K.

Clin Biochem. 2014 Nov 13. pii: S0009-9120(14)00747-4. doi: 10.1016/j.clinbiochem.2014.11.005. [Epub ahead of print]

PMID: 25448031 [PubMed - as supplied by publisher]

Related citations

Select item 25447792 144.

Immunogenicity of meningococcal quadrivalent (serogroup A, C, W135 and Y) tetanus toxoid conjugate vaccine: Systematic review and meta-analysis.

Pellegrino P, Perrone V, Radice S, Capuano A, Clementi E.

Pharmacol Res. 2014 Oct 30. pii: S1043-6618(14)00167-4. doi: 10.1016/j.phrs.2014.10.006. [Epub ahead of print] Review.

PMID: 25447792 [PubMed - as supplied by publisher]

Related citations

Select item 25447598 145.

Multivalent Nanomaterials: Learning from Vaccines and Progressing to Antigen- Specific Immunotherapies.

Hartwell BL, Antunez L, Sullivan BP, Thati S, Sestak JO, Berkland C.

J Pharm Sci. 2014 Dec 1. doi: 10.1002/jps.24273. [Epub ahead of print]

52

PMID: 25447598 [PubMed - as supplied by publisher]

Related citations

Select item 25447592 146.

Ongoing pharmacovigilance on vaccines.

Santuccio C, Trotta F, Felicetti P.

Pharmacol Res. 2014 Nov 10. pii: S1043-6618(14)00172-8. doi: 10.1016/j.phrs.2014.10.011. [Epub ahead of print] Review.

PMID: 25447592 [PubMed - as supplied by publisher]

Related citations

Select item 25447591 147.

On pharmacologist and vaccines: Present and future challenges.

Pellegrino P, Capuano A, Radice S.

Pharmacol Res. 2014 Nov 10. pii: S1043-6618(14)00171-6. doi: 10.1016/j.phrs.2014.10.010. [Epub ahead of print] No abstract available.

PMID: 25447591 [PubMed - as supplied by publisher]

Related citations

Select item 25447264 148.

Epidemiological analysis of an outbreak of foot-and-mouth disease (serotype SAT2) on a large dairy farm in Kenya using regular vaccination.

Lyons NA, Stärk KD, van Maanen C, Thomas SL, Chepkwony EC, Sangula AK, Dulu TD, Fine PE.

Acta Trop. 2014 Oct 24. pii: S0001-706X(14)00302-7. doi: 10.1016/j.actatropica.2014.09.010. [Epub ahead of print]

PMID: 25447264 [PubMed - as supplied by publisher]

53

Related citations

Select item 25447148 149.

Efficacy of bovine viral diarrhea virus vaccination to prevent reproductive disease: A meta-analysis.

Newcomer BW, Walz PH, Givens MD, Wilson AE.

Theriogenology. 2014 Oct 2. pii: S0093-691X(14)00520-2. doi: 10.1016/j.theriogenology.2014.09.028. [Epub ahead of print]

PMID: 25447148 [PubMed - as supplied by publisher]

Related citations

Select item 25446848 150.

Sub-isotypic differences in the immunoglobulin G response to Lawsonia intracellularis in vaccinated, seropositive, and equine proliferative enteropathy-affected horses.

Page AE, Stills HF Jr, Horohov DW.

Vet Immunol Immunopathol. 2014 Oct 2;162(3-4):162-167. doi: 10.1016/j.vetimm.2014.09.004. [Epub ahead of print]

PMID: 25446848 [PubMed - as supplied by publisher]

Related citations

Select item 25446834 151.

Seasonal variation in rates of emergency room visits and acute admissions following recommended infant vaccinations in Ontario, Canada: A self-controlled case series analysis.

Hawken S, Potter BK, Benchimol EI, Little J, Ducharme R, Wilson K.

Vaccine. 2014 Nov 1;32(52):7148-7153. doi: 10.1016/j.vaccine.2014.09.059. [Epub ahead of print]

PMID: 25446834 [PubMed - as supplied by publisher] Free Article

Related citations

54

Select item 25446831 152.

Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.

Babu TM, Levine M, Fitzgerald T, Luke C, Sangster MY, Jin H, Topham D, Katz J, Treanor J, Subbarao K.

Vaccine. 2014 Nov 28;32(50):6798-804. doi: 10.1016/j.vaccine.2014.09.070. Epub 2014 Oct 16.

PMID: 25446831 [PubMed - in process]

Related citations

Select item 25446830 153.

Safety and immunogenicity of dry powder administered by inhalation: A randomized controlled Phase I clinical trial.

MVDP author group, Agarkhedkar S, Kulkarni PS, Winston S, Sievers R, Dhere RM, Gunale B, Powell K, Rota PA, Papania M.

Vaccine. 2014 Nov 28;32(50):6791-7. doi: 10.1016/j.vaccine.2014.09.071. Epub 2014 Oct 22.

PMID: 25446830 [PubMed - in process]

Related citations

Select item 25446828 154.

Continued use of IBV 793B vaccine needs reassessment after its withdrawal led to the genotype's disappearance.

Franzo G, Naylor CJ, Lupini C, Drigo M, Catelli E, Listorti V, Pesente P, Giovanardi D, Morandini E, Cecchinato M.

Vaccine. 2014 Nov 28;32(50):6765-7. doi: 10.1016/j.vaccine.2014.10.006. Epub 2014 Oct 22.

PMID: 25446828 [PubMed - in process]

Related citations

55

Select item 25446827 155.

The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.

Kuo T, Wang C, Badakhshan T, Chilukuri S, BenMohamed L.

Vaccine. 2014 Nov 28;32(50):6733-6745. doi: 10.1016/j.vaccine.2014.10.002. Epub 2014 Oct 16. Review.

PMID: 25446827 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 25446826 156.

Integration of vaccine supply chains with other health commodity supply chains: A framework for decision making.

Yadav P, Lydon P, Oswald J, Dicko M, Zaffran M.

Vaccine. 2014 Nov 28;32(50):6725-6732. doi: 10.1016/j.vaccine.2014.10.001. Epub 2014 Oct 23. Review.

PMID: 25446826 [PubMed - as supplied by publisher]

Related citations

Select item 25446825 157.

Human papillomavirus vaccine uptake among males 11-26 years in United States: Findings from the National Health and Nutrition Examination Survey, 2011-2012.

Pierre-Victor D, Mukherjee S, Bahelah R, Madhivanan P.

Vaccine. 2014 Oct 18;32(49):6655-6658. doi: 10.1016/j.vaccine.2014.09.044. [Epub ahead of print]

PMID: 25446825 [PubMed - as supplied by publisher]

Related citations

Select item 25446824 158.

56

Adverse events and association with age, sex and immunological parameters of vaccination in patients at risk for chronic Q fever in the Netherlands 2011.

Schoffelen T, Wong A, Rümke HC, Netea MG, Timen A, van Deuren M, Vermeer-de Bondt PE.

Vaccine. 2014 Oct 16;32(49):6622-6630. doi: 10.1016/j.vaccine.2014.09.061. [Epub ahead of print]

PMID: 25446824 [PubMed - as supplied by publisher]

Related citations

Select item 25446822 159.

International meeting on influenza vaccine effectiveness, 3-4 December 2012, Geneva, Switzerland.

Lafond KE, Tam JS, Bresee JS, Widdowson MA.

Vaccine. 2014 Oct 16;32(49):6591-6595. doi: 10.1016/j.vaccine.2014.09.069. [Epub ahead of print]

PMID: 25446822 [PubMed - as supplied by publisher]

Related citations

Select item 25446821 160.

The transcriptional program of vaccine-induced CD8+ T cell memory.

Roychoudhuri R, Lefebvre F, Honda M, Pan L, Ji Y, Klebanoff CA, Nichols C, Fourati S, Hegazy AN, Goulet JP, Gattinoni L, Nabel GJ, Gilliet M, Cameron M, Restifo NP, Sékaly RP, Flatz L.

Vaccine. 2014 Nov 1. pii: S0264-410X(14)01367-X. doi: 10.1016/j.vaccine.2014.10.007. [Epub ahead of print]

PMID: 25446821 [PubMed - as supplied by publisher]

Related citations

Select item 25446819 161.

Live virus vaccines based on a vaccine backbone: Standardized template with key considerations for a risk/benefit assessment. 57

Monath TP, Seligman SJ, Robertson JS, Guy B, Hayes EB, Condit RC, Excler JL, Mac LM, Carbery B, Chen RT; The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).

Vaccine. 2014 Oct 27. pii: S0264-410X(14)01364-4. doi: 10.1016/j.vaccine.2014.10.004. [Epub ahead of print]

PMID: 25446819 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25446818 162.

Measles-mumps-ru bella vaccination and respiratory syncytial virus-associated hospital contact.

Sørup S, Benn CS, Stensballe LG, Aaby P, Ravn H.

Vaccine. 2014 Nov 1. pii: S0264-410X(14)01175-X. doi: 10.1016/j.vaccine.2014.07.110. [Epub ahead of print]

PMID: 25446818 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25446313 163.

[Influenza, tetanus, and pertussis vaccination coverage among adults in Germany.]

Bödeker B, Remschmidt C, Müters S, Wichmann O.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Dec 2. [Epub ahead of print] German.

PMID: 25446313 [PubMed - as supplied by publisher]

Related citations

Select item 25445338 164.

Measles virus genetic evolution throughout an imported epidemic outbreak in a highly vaccinated population.

58

Muñoz-Alía MA, Fernández-Muñoz R, Casasnovas JM, Porras-Mansilla R, Serrano-Pardo A, Pagán I, Ordobás M, Ramírez R, Celma ML.

Virus Res. 2014 Nov 20. pii: S0168-1702(14)00475-4. doi: 10.1016/j.virusres.2014.11.015. [Epub ahead of print]

PMID: 25445338 [PubMed - as supplied by publisher]

Related citations

Select item 25445336 165.

Receptor-binding domain-based subunit vaccines against MERS-CoV.

Zhang N, Tang J, Lu L, Jiang S, Du L.

Virus Res. 2014 Nov 20. pii: S0168-1702(14)00473-0. doi: 10.1016/j.virusres.2014.11.013. [Epub ahead of print]

PMID: 25445336 [PubMed - as supplied by publisher]

Related citations

Select item 25445329 166.

Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development.

Stephenson KE, Neubauer GH, Reimer U, Pawlowski N, Knaute T, Zerweck J, Korber BT, Barouch DH.

J Immunol Methods. 2014 Nov 15. pii: S0022-1759(14)00319-6. doi: 10.1016/j.jim.2014.11.006. [Epub ahead of print]

PMID: 25445329 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25445326 167.

Vaccine-induced plasmablast responses in rhesus macaques: Phenotypic characterization and a source for generating antigen-specific monoclonal antibodies.

Silveira EL, Kasturi SP, Kovalenkov Y, Rasheed AU, Yeiser P, Jinnah ZS, Legere TH, Pulendran B, Villinger F, Wrammert J. 59

J Immunol Methods. 2014 Nov 8. pii: S0022-1759(14)00315-9. doi: 10.1016/j.jim.2014.11.003. [Epub ahead of print]

PMID: 25445326 [PubMed - as supplied by publisher]

Related citations

Select item 25445123 168.

[Acute disseminated encephalomyelitis after rabies vaccination: A case report.]

Arrab R, Draiss G, Rada N, Bourouss M, Bouskraoui M.

Arch Pediatr. 2014 Oct 27. pii: S0929-693X(14)00430-8. doi: 10.1016/j.arcped.2014.09.015. [Epub ahead of print] French.

PMID: 25445123 [PubMed - as supplied by publisher]

Related citations

Select item 25445117 169.

Emergence of serogroup 15 Streptococcus pneumoniae of diverse genetic backgrounds following the introduction of pneumococcal conjugate vaccines in Hong Kong.

Liyanapathirana V, Nelson EA, Ang I, Subramanian R, Ma H, Ip M.

Diagn Microbiol Infect Dis. 2014 Oct 2. pii: S0732-8893(14)00408-8. doi: 10.1016/j.diagmicrobio.2014.09.028. [Epub ahead of print]

PMID: 25445117 [PubMed - as supplied by publisher]

Related citations

Select item 25444836 170.

[Seasonal influenza vaccination coverage of general practitioners and their patients. Practice survey of French general practitioners after vaccination campaign 2011- 2012.]

Joseph JP, Staffolani F, Kinouani S, Broussy S, Picat MQ, Senand B, Ducos G.

Rev Epidemiol Sante Publique. 2014 Oct 16;62(5):291-296. doi: 10.1016/j.respe.2014.07.003. [Epub ahead of print] French.

60

PMID: 25444836 [PubMed - as supplied by publisher]

Related citations

Select item 25444830 171.

Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.

Lundgren A, Bourgeois L, Carlin N, Clements J, Gustafsson B, Hartford M, Holmgren J, Petzold M, Walker R, Svennerholm AM.

Vaccine. 2014 Nov 5;32(52):7077-7084. doi: 10.1016/j.vaccine.2014.10.069. [Epub ahead of print]

PMID: 25444830 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25444827 172.

The use of serosurveys following emergency vaccination, to recover the status of "foot-and-mouth disease free where vaccination is not practised"

Paton DJ, Füssel AE, Vosloo W, Dekker A, De Clercq K.

Vaccine. 2014 Nov 5;32(52):7050-7056. doi: 10.1016/j.vaccine.2014.10.064. [Epub ahead of print] Review.

PMID: 25444827 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25444825 173.

Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain.

Gil-Prieto R, Garcia-Garcia L, San-Martin M, Gil-de-Miguel A.

Vaccine. 2014 Nov 6;32(52):7043-7046. doi: 10.1016/j.vaccine.2014.10.076. [Epub ahead of print]

61

PMID: 25444825 [PubMed - as supplied by publisher]

Related citations

Select item 25444824 174.

Seasonal and pandemic influenza vaccine: Demand, supply and vaccine availability.

Gellin BG, Ampofo WK.

Vaccine. 2014 Nov 5;32(52):7037-7039. doi: 10.1016/j.vaccine.2014.10.062. [Epub ahead of print] No abstract available.

PMID: 25444824 [PubMed - as supplied by publisher]

Related citations

Select item 25444823 175.

Early indication for a reduced burden of radiologically confirmed pneumonia in children following the introduction of routine vaccination against Haemophilus influenzae type b in Nha Trang, Vietnam.

Flasche S, Takahashi K, Vu DT, Suzuki M, Nguyen TH, Le H, Hashizume M, Dang DA, Edmond K, Ariyoshi K, Mulholland EK, Edmunds WJ, Yoshida LM.

Vaccine. 2014 Nov 1;32(51):6963-6970. doi: 10.1016/j.vaccine.2014.10.055. [Epub ahead of print]

PMID: 25444823 [PubMed - as supplied by publisher]

Related citations

Select item 25444822 176.

Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.

Brewer KD, Lake K, Pelot N, Stanford MM, DeBay DR, Penwell A, Weir GM, Karkada M, Mansour M, Bowen CV.

Vaccine. 2014 Nov 4;32(51):6956-6962. doi: 10.1016/j.vaccine.2014.10.058. [Epub ahead of print]

PMID: 25444822 [PubMed - as supplied by publisher] 62

Related citations

Select item 25444821 177.

Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media.

Daly KA, Scott Giebink G, Lindgren BR, Knox J, Haggerty BJ, Nordin J, Goetz S, Ferrieri P.

Vaccine. 2014 Oct 30;32(51):6948-6955. doi: 10.1016/j.vaccine.2014.10.060. [Epub ahead of print]

PMID: 25444821 [PubMed - as supplied by publisher]

Related citations

Select item 25444820 178.

Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high- grade anal intraepithelial neoplasia.

Deshmukh AA, Chiao EY, Das P, Cantor SB.

Vaccine. 2014 Nov 1;32(51):6941-6947. doi: 10.1016/j.vaccine.2014.10.052. [Epub ahead of print]

PMID: 25444820 [PubMed - as supplied by publisher]

Related citations

Select item 25444819 179.

Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.

Singh S, Yang G, Byrareddy SN, Barry MA, Sastry KJ.

Vaccine. 2014 Nov 2;32(51):6934-6940. doi: 10.1016/j.vaccine.2014.10.051. [Epub ahead of print]

PMID: 25444819 [PubMed - as supplied by publisher]

Related citations

63

Select item 25444815 180.

Repeated vaccinations do not improve specific immune defenses against Hepatitis B in non-responder health care workers.

Zaffina S, Marcellini V, Santoro AP, Scarsella M, Camisa V, Vinci MR, Musolino AM, Nicolosi L, Rosado MM, Carsetti R.

Vaccine. 2014 Nov 5;32(51):6902-6910. doi: 10.1016/j.vaccine.2014.10.066. [Epub ahead of print]

PMID: 25444815 [PubMed - as supplied by publisher]

Related citations

Select item 25444812 181.

Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-l-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy.

Miller E, Spadaccia M, Sabado R, Chertova E, Bess J, Trubey CM, Holman RM, Salazar A, Lifson J, Bhardwaj N.

Vaccine. 2014 Nov 15. pii: S0264-410X(14)01444-3. doi: 10.1016/j.vaccine.2014.10.054. [Epub ahead of print]

PMID: 25444812 [PubMed - as supplied by publisher]

Related citations

Select item 25444811 182.

Optimizing energy for a 'green' vaccine supply chain.

Lloyd JS, McCarney S, Ouhichi R, Lydon P, Zaffran M.

Vaccine. 2014 Nov 17. pii: S0264-410X(14)01443-1. doi: 10.1016/j.vaccine.2014.10.053. [Epub ahead of print]

PMID: 25444811 [PubMed - as supplied by publisher] Free Article

Related citations

64

Select item 25444810 183.

Reducing the loss of vaccines from accidental freezing in the cold chain: The experience of continuous temperature monitoring in Tunisia.

Lloyd J, Lydon P, Ouichi R, Zaffran M.

Vaccine. 2014 Nov 8. pii: S0264-410X(14)01480-7. doi: 10.1016/j.vaccine.2014.10.080. [Epub ahead of print]

PMID: 25444810 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25444808 184.

A perspective on the use of Pleurotus for the development of convenient fungi-made oral subunit vaccines.

Pérez-Martínez AS, Acevedo-Padilla SA, Bibbins-Martínez M, Galván-Alonso J, Rosales- Mendoza S.

Vaccine. 2014 Nov 4. pii: S0264-410X(14)01449-2. doi: 10.1016/j.vaccine.2014.10.059. [Epub ahead of print] Review.

PMID: 25444808 [PubMed - as supplied by publisher]

Related citations

Select item 25444807 185.

Considerations for developing an immunization strategy with enterovirus 71 vaccine.

Li L, Yin H, An Z, Feng Z.

Vaccine. 2014 Nov 8. pii: S0264-410X(14)01500-X. doi: 10.1016/j.vaccine.2014.10.081. [Epub ahead of print] Review.

PMID: 25444807 [PubMed - as supplied by publisher]

Related citations

Select item 25444806 186.

65

CD4+ T-cells, γδ T-cells and B-cells are associated with lack of vaccine protection in Mycobacterium avium subspecies paratuberculosis infection. de Silva K, M Plain K, J Begg D, C Purdie A, J Whittington R.

Vaccine. 2014 Nov 8. pii: S0264-410X(14)01501-1. doi: 10.1016/j.vaccine.2014.10.082. [Epub ahead of print]

PMID: 25444806 [PubMed - as supplied by publisher]

Related citations

Select item 25444805 187.

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009- 2010 seasonal trivalent influenza vaccinations.

Frey SE, Bernstein DI, Brady RC, Keitel WA, Sahly HE, Rouphael NG, Mulligan MJ, Atmar RL, Edupuganti S, Patel SM, Dickey M, Graham I, Anderson EL, Noah DL, Hill H, Wolff M, Belshe RB.

Vaccine. 2014 Nov 11. pii: S0264-410X(14)01502-3. doi: 10.1016/j.vaccine.2014.10.083. [Epub ahead of print]

PMID: 25444805 [PubMed - as supplied by publisher]

Related citations

Select item 25444804 188.

Vaccination of pigs with attenuated Lawsonia intracellularis induced acute phase protein responses and primed cell-mediated immunity without reduction in bacterial shedding after challenge.

Riber U, Heegaard PM, Cordes H, Ståhl M, Jensen TK, Jungersen G.

Vaccine. 2014 Nov 11. pii: S0264-410X(14)01503-5. doi: 10.1016/j.vaccine.2014.10.084. [Epub ahead of print]

PMID: 25444804 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25444803 189.

66

Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.

Knuf M, Leroux-Roels G, Rümke HC, Abarca K, Rivera L, Lattanzi M, Pedotti P, Arora A, Kieninger-Baum D, Della Cioppa G.

Vaccine. 2014 Nov 11. pii: S0264-410X(14)01504-7. doi: 10.1016/j.vaccine.2014.10.085. [Epub ahead of print]

PMID: 25444803 [PubMed - as supplied by publisher]

Related citations

Select item 25444802 190.

Seasonal influenza vaccination rates and reasons for non-vaccination in children with gastrointestinal disorders.

Peleg N, Zevit N, Shamir R, Chodick G, Levy I.

Vaccine. 2014 Nov 11. pii: S0264-410X(14)01505-9. doi: 10.1016/j.vaccine.2014.10.086. [Epub ahead of print]

PMID: 25444802 [PubMed - as supplied by publisher]

Related citations

Select item 25444800 191.

Use of a current as a live polyvalent vaccine vector.

Murakami K, Mori Y.

Vaccine. 2014 Nov 11. pii: S0264-410X(14)01508-4. doi: 10.1016/j.vaccine.2014.11.001. [Epub ahead of print] Review.

PMID: 25444800 [PubMed - as supplied by publisher]

Related citations

Select item 25444799 192.

Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates.

67

Broadbent AJ, Santos CP, Paskel M, Matsuoka Y, Lu J, Chen Z, Jin H, Subbarao K.

Vaccine. 2014 Nov 6. pii: S0264-410X(14)01455-8. doi: 10.1016/j.vaccine.2014.10.065. [Epub ahead of print]

PMID: 25444799 [PubMed - as supplied by publisher]

Related citations

Select item 25444798 193.

Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.

Ropero-Álvarez AM, Whittembury A, Bravo-Alcántara P, Kurtis HJ, Danovaro-Holliday MC, Velandia-González M.

Vaccine. 2014 Nov 6. pii: S0264-410X(14)01460-1. doi: 10.1016/j.vaccine.2014.10.070. [Epub ahead of print]

PMID: 25444798 [PubMed - as supplied by publisher]

Related citations

Select item 25444797 194.

Febrile seizures following measles and varicella vaccines in young children in Australia.

Macartney KK, Gidding HF, Trinh L, Wang H, McRae J, Crawford N, Gold M, Kynaston A, Blyth C, Wood N, Yvonne Z, Elliott E, Booy R, Buttery J, Marshall H, Nissen M, Richmond P, McInytre PB.

Vaccine. 2014 Nov 7. pii: S0264-410X(14)01461-3. doi: 10.1016/j.vaccine.2014.10.071. [Epub ahead of print]

PMID: 25444797 [PubMed - as supplied by publisher]

Related citations

Select item 25444794 195.

What predicts postpartum pertussis booster vaccination? A controlled intervention trial.

Hayles EH, Cooper SC, Wood N, Sinn J, Skinner SR. 68

Vaccine. 2014 Nov 7. pii: S0264-410X(14)01464-9. doi: 10.1016/j.vaccine.2014.10.074. [Epub ahead of print]

PMID: 25444794 [PubMed - as supplied by publisher]

Related citations

Select item 25444793 196.

Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine.

Sundararajan A, Sangster MY, Frey S, Atmar RL, Chen WH, Ferreira J, Bargatze R, Mendelman PM, Treanor JJ, Topham DJ.

Vaccine. 2014 Nov 22. pii: S0264-410X(14)01465-0. doi: 10.1016/j.vaccine.2014.09.073. [Epub ahead of print]

PMID: 25444793 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25444792 197.

On birth single dose live attenuated OPV and BCG vaccination induces gut cathelicidin LL37 responses at 6 week of age: A natural experiment.

Alam MJ, Rashid MM, Kabir Y, Raqib R, Ahmad SM.

Vaccine. 2014 Nov 13. pii: S0264-410X(14)01466-2. doi: 10.1016/j.vaccine.2014.10.075. [Epub ahead of print]

PMID: 25444792 [PubMed - as supplied by publisher]

Related citations

Select item 25444791 198.

Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors.

Chit A, Roiz J, Briquet B, Greenberg DP.

Vaccine. 2014 Nov 11. pii: S0264-410X(14)01479-0. doi: 10.1016/j.vaccine.2014.10.079. [Epub ahead of print]

69

PMID: 25444791 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25444790 199.

Rescue of a vaccine strain of peste des petits ruminants virus: In vivo evaluation and comparison with standard vaccine.

Muniraju M, Mahapatra M, Buczkowski H, Batten C, Banyard AC, Parida S.

Vaccine. 2014 Nov 1. pii: S0264-410X(14)01440-6. doi: 10.1016/j.vaccine.2014.10.050. [Epub ahead of print]

PMID: 25444790 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25444788 200.

The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.

Lopalco PL, DeStefano F.

Vaccine. 2014 Nov 4. pii: S0264-410X(14)01437-6. doi: 10.1016/j.vaccine.2014.10.047. [Epub ahead of print] Review.

PMID: 25444788 [PubMed - as supplied by publisher]

Related citations Select item 25444787 201.

Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.

Osborne SL, Tabrizi SN, Brotherton JM, Cornall AM, Wark JD, Wrede CD, Jayasinghe Y, Gertig DM, Pitts MK, Garland SM; VACCINE Study group.

Vaccine. 2014 Nov 1. pii: S0264-410X(14)01435-2. doi: 10.1016/j.vaccine.2014.10.045. [Epub ahead of print]

PMID: 25444787 [PubMed - as supplied by publisher]

70

Related citations

Select item 25444786 202.

Childhood vaccines and Kawasaki disease, , 1996-2006.

Abrams JY, Weintraub ES, Baggs JM, McCarthy NL, Schonberger LB, Lee GM, Klein NP, Belongia EA, Jackson ML, Naleway AL, Nordin JD, Hambidge SJ, Belay ED.

Vaccine. 2014 Nov 4. pii: S0264-410X(14)01434-0. doi: 10.1016/j.vaccine.2014.10.044. [Epub ahead of print]

PMID: 25444786 [PubMed - as supplied by publisher]

Related citations

Select item 25444784 203.

Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age.

Li X, Zhang JH, Betts RF, Morrison VA, Xu R, Itzler RF, Acosta CJ, Dasbach EJ, Pellissier JM, Johnson GR, Chan IS.

Vaccine. 2014 Nov 6. pii: S0264-410X(14)01429-7. doi: 10.1016/j.vaccine.2014.10.039. [Epub ahead of print]

PMID: 25444784 [PubMed - as supplied by publisher]

Related citations

Select item 25444783 204.

Comparing the efficacy of FeLV vaccines: Comment on: Stuke, K. et al. Efficacy of an inactivated FeLV vaccine compared to a recombinant FeLV vaccine in minimum age cats following virulent FeLV challenge. Vaccine 2014;32(22):2599-603.

Hofmann-Lehmann R, Levy LS, Willett BJ.

Vaccine. 2014 Nov 15. pii: S0264-410X(14)01428-5. doi: 10.1016/j.vaccine.2014.10.038. [Epub ahead of print] No abstract available.

PMID: 25444783 [PubMed - as supplied by publisher]

Related citations

71

Select item 25444782 205.

Knowledge and attitudes regarding human papillomavirus vaccination among young women recruited using Facebook.

Gunasekaran B, Jayasinghe Y, Brotherton JM, Fenner Y, Moore EE, Wark JD, Fletcher A, Tabrizi SN, Garland SM.

Vaccine. 2014 Nov 12. pii: S0264-410X(14)01509-6. doi: 10.1016/j.vaccine.2014.11.002. [Epub ahead of print]

PMID: 25444782 [PubMed - as supplied by publisher]

Related citations

Select item 25444781 206.

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.

Leroux-Roels G, Van Belle P, Vandepapeliere P, Horsmans Y, Janssens M, Carletti I, Garçon N, Wettendorff M, Van Mechelen M.

Vaccine. 2014 Nov 7. pii: S0264-410X(14)01469-8. doi: 10.1016/j.vaccine.2014.10.078. [Epub ahead of print]

PMID: 25444781 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25444695 207.

Effectiveness of the Typhoid Vi Vaccine in Overseas Travelers from England.

Wagner KS, Freedman JL, Andrews NJ, Jones JA.

J Travel Med. 2014 Nov 30. doi: 10.1111/jtm.12178. [Epub ahead of print]

PMID: 25444695 [PubMed - as supplied by publisher]

Related citations

Select item 25444525 208. 72

Vaccinating My Way-Use of Alternative Vaccination Schedules in New York State.

Nadeau JA, Bednarczyk RA, Masawi MR, Meldrum MD, Santilli L, Zansky SM, Blog DS, Birkhead GS, McNutt LA.

J Pediatr. 2014 Oct 16. pii: S0022-3476(14)00840-3. doi: 10.1016/j.jpeds.2014.09.013. [Epub ahead of print]

PMID: 25444525 [PubMed - as supplied by publisher]

Related citations

Select item 25444387 209.

Predictors of having heard about human papillomavirus vaccination: Critical aspects for cervical cancer prevention among Colombian women.

Bermedo-Carrasco S, Feng CX, Peña-Sánchez JN, Lepnurm R.

Gac Sanit. 2014 Oct 25. pii: S0213-9111(14)00240-4. doi: 10.1016/j.gaceta.2014.09.005. [Epub ahead of print]

PMID: 25444387 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25443345 210.

A prophylactic hepatitis C virus vaccine: A distant peak still worth climbing.

Baumert TF, Fauvelle C, Chen DY, Lauer GM.

J Hepatol. 2014 Nov;61(1S):S34-S44. doi: 10.1016/j.jhep.2014.09.009. Epub 2014 Nov 3. Review.

PMID: 25443345 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25442682 211.

Inactivated launch in Nepal: a public health milestone.

73

Hasman A, Raaijmakers HC, Noble DJ.

Lancet Glob Health. 2014 Nov;2(11):e627-8. doi: 10.1016/S2214-109X(14)70324-9. Epub 2014 Oct 22. No abstract available.

PMID: 25442682 [PubMed - in process] Free Article

Related citations

Select item 25442403 212.

Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).

Palache A, Oriol-Mathieu V, Abelin A, Music T; on behalf of the Influenza Vaccine Supply task force (IFPMA IVS).

Vaccine. 2014 Nov 12;32(48):6369-6376. doi: 10.1016/j.vaccine.2014.07.012. Epub 2014 Nov 1. Review.

PMID: 25442403 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25442122 213.

[Programming and implementation a meningitis vaccination campaign in Africa.]

Pérez-Manchón D.

Enferm Clin. 2014 Oct 24. pii: S1130-8621(14)00085-0. doi: 10.1016/j.enfcli.2014.06.002. [Epub ahead of print] Spanish. No abstract available.

PMID: 25442122 [PubMed - as supplied by publisher]

Related citations

Select item 25441634 214.

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.

Focke-Tejkl M, Weber M, Niespodziana K, Neubauer A, Huber H, Henning R, Stegfellner G, Maderegger B, Hauer M, Stolz F, Niederberger V, Marth K, Eckl-Dorna J, Weiss R, Thalhamer J, Blatt K, Valent P, Valenta R. 74

J Allergy Clin Immunol. 2014 Nov 13. pii: S0091-6749(14)01322-0. doi: 10.1016/j.jaci.2014.09.012. [Epub ahead of print]

PMID: 25441634 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25441389 215.

Vaccine promotion messages may not encourage vaccination.

Campbell H, Bedford H.

J Pediatr. 2014 Nov;165(5):1068-71. doi: 10.1016/j.jpeds.2014.08.017. Epub 2014 Oct 21. No abstract available.

PMID: 25441389 [PubMed - in process]

Related citations

Select item 25441187 216.

Adrian Hill: accelerating the pace of Ebola vaccine research.

Mohammadi D.

Lancet. 2014 Nov 8;384(9955):1660. doi: 10.1016/S0140-6736(14)61738-4. Epub 2014 Nov 3. No abstract available.

PMID: 25441187 [PubMed - in process]

Related citations

Select item 25441027 217.

[Vaccination of patients with hereditary hemorrhagic telangiectasia.]

Rodríguez-García J, Fernández-Santos R, Zarrabeitia-Puente R, García-Erce JA.

Med Clin (Barc). 2014 Nov 24. pii: S0025-7753(14)00631-9. doi: 10.1016/j.medcli.2014.09.003. [Epub ahead of print] Spanish. No abstract available.

PMID: 25441027

75

[PubMed - as supplied by publisher]

Related citations

Select item 25439650 218.

Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces , viral shedding and transmission of the virus in a quasi-natural experimental model.

Pileri E, Gibert E, Soldevila F, García-Saenz A, Pujols J, Diaz I, Darwich L, Casal J, Martín M, Mateu E.

Vet Microbiol. 2014 Nov 15. pii: S0378-1135(14)00519-7. doi: 10.1016/j.vetmic.2014.11.007. [Epub ahead of print]

PMID: 25439650 [PubMed - as supplied by publisher]

Related citations

Select item 25439092 219.

Chicken anemia virus and avian gyrovirus 2 as contaminants in poultry vaccines.

Varela AP, Dos Santos HF, Cibulski SP, Scheffer CM, Schmidt C, Sales Lima FE, Silva AD, Esteves PA, Franco AC, Roehe PM.

Biologicals. 2014 Nov;42(6):346-50. doi: 10.1016/j.biologicals.2014.08.002. Epub 2014 Oct 27.

PMID: 25439092 [PubMed - in process]

Related citations

Select item 25438965 220.

A Randomized Intervention of Reminder Letter for Human Papillomavirus Vaccine Series Completion.

Chao C, Preciado M, Slezak J, Xu L.

J Adolesc Health. 2014 Nov 1. pii: S1054-139X(14)00346-2. doi: 10.1016/j.jadohealth.2014.08.014. [Epub ahead of print]

PMID: 25438965 [PubMed - as supplied by publisher]

76

Related citations

Select item 25438764 221.

Self-adjuvanting vaccine against group A streptococcus: Application of fibrillized peptide and immunostimulatory lipid as adjuvant.

Azmi F, Ahmad Fuaad AA, Giddam AK, Batzloff MR, Good MF, Skwarczynski M, Toth I.

Bioorg Med Chem. 2014 Nov 15;22(22):6401-8. doi: 10.1016/j.bmc.2014.09.042. Epub 2014 Sep 26.

PMID: 25438764 [PubMed - in process]

Related citations

Select item 25438520 222.

Human papilloma virus vaccine: determinants of acceptability by mothers for adolescents in Nigeria.

Ezeanochie MC, Olagbuji BN.

Afr J Reprod Health. 2014 Sep;18(3):154-8.

PMID: 25438520 [PubMed - in process]

Related citations

Select item 25438463 223.

Vaccination in autoimmune animal models.

Tomijenovic L, Arango MT, Agmon-Levin N.

Isr Med Assoc J. 2014 Oct;16(10):657-8. No abstract available.

PMID: 25438463 [PubMed - in process] Free Article

Related citations

Select item 25438454 224.

77

Narcolepsy--genes, and vaccines: the clues for a new autoimmune disease.

Arango MT, Kivity S, Chapman J, Shoenfeld Y.

Isr Med Assoc J. 2014 Oct;16(10):636-7. No abstract available.

PMID: 25438454 [PubMed - in process] Free Article

Related citations

Select item 25437035 225.

Use of a Th1 Stimulator Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant Mouse Model.

Monney T, Grandgirard D, Leib SL, Hemphill A.

Pathogens. 2013 Mar 27;2(2):193-208.

PMID: 25437035 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 25436552 226.

Memory immune response: a major challenge in vaccination.

Prisco A, De Berardinis P.

Biomol Concepts. 2012 Oct;3(5):479-86. doi: 10.1515/bmc-2012-0010.

PMID: 25436552 [PubMed - in process]

Related citations

Select item 25437625 227.

[Vaccination against HPV-Associated Neoplasias].

Gross G, Becker N, Brockmeyer NH, Esser S, Freitag U, Gebhardt M, Gissmann L, Hillemanns P, Grundhewer H, Ikenberg H, Jessen H, Kaufmann A, Klug S, Klussmann JP, Nast A, Pathirana D, Petry KU, Pfister H, Röllinghof U, Schneede P, Schneider A, Selka E, Singer S, Smola S, Sporbeck B, von Knebel Doeberitz M, Wutzler P.

78

Laryngorhinootologie. 2014 Dec;93(12):848-56. doi: 10.1055/s-0034-1382013. Epub 2014 Dec 1. German. No abstract available.

PMID: 25437625 [PubMed - in process]

Related citations

Select item 25437502 228.

Prevalence of Rotavirus Genotypes in Children Younger than 5 Years of Age before the Introduction of a Universal Rotavirus Vaccination Program: Report of Rotavirus Surveillance in Turkey.

Durmaz R, Kalaycioglu AT, Acar S, Bakkaloglu Z, Karagoz A, Korukluoglu G, Ertek M, Torunoglu MA; Turkish Rotavirus Surveillance Network.

PLoS One. 2014 Dec 1;9(12):e113674. doi: 10.1371/journal.pone.0113674. eCollection 2014.

PMID: 25437502 [PubMed - in process] Free Article

Related citations

Select item 25437322 229.

Acute disseminated encephalomyelitis following influenza vaccine.

Pellegrino P, Radice S, Clementi E.

Epidemiology. 2015 Jan;26(1):e12-3. doi: 10.1097/EDE.0000000000000210. No abstract available.

PMID: 25437322 [PubMed - in process]

Related citations

Select item 25437101 230.

Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.

Thomas M, Wang Z, Sreenivasan CC, Hause BM, Gourapura R, Li F, Francis DH, Kaushik RS, Khatri M.

79

Vaccine. 2014 Nov 28. pii: S0264-410X(14)01573-4. doi: 10.1016/j.vaccine.2014.11.034. [Epub ahead of print]

PMID: 25437101 [PubMed - as supplied by publisher]

Related citations

Select item 25437100 231.

Introducing cholera vaccination in Asia, Africa and Haiti: A meeting report.

Hall RH, Sack DA.

Vaccine. 2014 Nov 28. pii: S0264-410X(14)01570-9. doi: 10.1016/j.vaccine.2014.11.031. [Epub ahead of print]

PMID: 25437100 [PubMed - as supplied by publisher]

Related citations

Select item 25436508 232.

Animal Models for Influenza Viruses: Implications for Universal Vaccine Development.

Margine I, Krammer F.

Pathogens. 2014 Oct 21;3(4):845-874. Review.

PMID: 25436508 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25435557 233.

Capacity Building Among African American Faith Leaders to Promote HIV Prevention and Vaccine Research.

Alio AP, Lewis CA, Bunce CA, Wakefield S, Thomas WG, Sanders E, Keefer MC.

Prog Community Health Partnersh. 2014 Fall;8(3):305-16. doi: 10.1353/cpr.2014.0050.

PMID: 25435557

80

[PubMed - in process]

Related citations

Select item 25435552 234.

Capacity Building Among African American Faith Leaders to Promote HIV Prevention and Vaccine Research.

Alio AP, Lewis CA, Bunce CA, Wakefield S, Thomas WG, Sanders E, Keefer MC.

Prog Community Health Partnersh. 2014 Fall;8(3):265-6. doi: 10.1353/cpr.2014.0035. No abstract available.

PMID: 25435552 [PubMed - in process]

Related citations

Select item 25435196 235.

Short message service broadcasting to improve the uptake of influenza vaccination in HIV-positive patients at a metropolitan sexual health clinic.

Stowers C, Healey L, O'Connor CC.

Sex Health. 2014 Dec;11(6):590-1. doi: 10.1071/SH14162.

PMID: 25435196 [PubMed - in process]

Related citations

Select item 25435003 236.

Analytics for vaccine economics and pricing: insights and observations.

Robbins MJ, Jacobson SH.

Expert Rev Vaccines. 2014 Dec 1:1-12. [Epub ahead of print]

PMID: 25435003 [PubMed - as supplied by publisher]

Related citations

Select item 25434995 237.

81

Effect of booster shot and investigation of vaccination efficacy period against herpesviral haematopoietic necrosis (HVHN) in goldfish Carassius auratus.

Ito T, Maeno Y.

Vet Microbiol. 2014 Nov 15. pii: S0378-1135(14)00517-3. doi: 10.1016/j.vetmic.2014.11.005. [Epub ahead of print]

PMID: 25434995 [PubMed - as supplied by publisher]

Related citations

Select item 25434842 238.

Japan's Failure to Vaccinate Girls against HPV.

Ueda Y, Enomoto T, Egawa-Takata T, Morimoto A, Sekine M, Kimura T.

Am J Obstet Gynecol. 2014 Nov 27. pii: S0002-9378(14)02361-8. doi: 10.1016/j.ajog.2014.11.037. [Epub ahead of print] No abstract available.

PMID: 25434842 [PubMed - as supplied by publisher]

Related citations

Select item 25434527 239.

A novel method for construction based on protein assembly.

Liu Z, Zhou H, Wang W, Tan W, Fu YX, Zhu M.

Sci Rep. 2014 Dec 1;4:7266. doi: 10.1038/srep07266.

PMID: 25434527 [PubMed - in process]

Related citations

Select item 25434104 240.

Assessment of phagosomes infected with Mycobacterium tuberculosis as a vaccine candidate against tuberculosis.

Sharma A, Parihar P, Sharma J.

Indian J Exp Biol. 2014 Nov;52(11):1090-7.

82

PMID: 25434104 [PubMed - in process]

Related citations

Select item 25433619 241.

Hyperimmune serum from healthy vaccinated individuals for Ebola virus disease?

Almansa R, Eiros JM, Fedson D, Bermejo-Martin JF.

Lancet Glob Health. 2014 Dec;2(12):e686. doi: 10.1016/S2214-109X(14)70341-9. Epub 2014 Oct 30. No abstract available.

PMID: 25433619 [PubMed - in process] Free Article

Related citations

Select item 25433534 242.

Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414.

Cunliffe N, Zaman K, Rodrigo C, Debrus S, Benninghoff B, Pemmaraju Venkata S, Han HH.

BMC Pediatr. 2014 Nov 30;14(1):295. [Epub ahead of print]

PMID: 25433534 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 25433216 243.

Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.

Pakkanen SH, Kantele JM, Savolainen LE, Rombo L, Kantele A.

Vaccine. 2014 Nov 26. pii: S0264-410X(14)01569-2. doi: 10.1016/j.vaccine.2014.11.030. [Epub ahead of print]

PMID: 25433216 [PubMed - as supplied by publisher] 83

Free Article

Related citations

Select item 25433189 244.

Factors Associated with HPV Vaccine Use Among Hispanic College Students.

Cohen TF, Legg JS.

J Allied Health. 2014 Winter;43(4):241-6.

PMID: 25433189 [PubMed - in process]

Related citations

Select item 25433130 245.

Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens.

Balasubramaniyan M, Santhanam M, Devasena T, Perumal K.

Int J Biol Macromol. 2014 Nov 26. pii: S0141-8130(14)00762-4. doi: 10.1016/j.ijbiomac.2014.11.014. [Epub ahead of print]

PMID: 25433130 [PubMed - as supplied by publisher]

Related citations

Select item 25432943 246.

TB vaccine development: where are we and why is it so difficult?

Wilkie ME, McShane H.

Thorax. 2014 Nov 28. pii: thoraxjnl-2014-205202. doi: 10.1136/thoraxjnl-2014- 205202. [Epub ahead of print]

PMID: 25432943 [PubMed - as supplied by publisher] Free Article

Related citations

84

Select item 25432792 247.

In planta Production of Flock House Virus Transencapsidated RNA and Its Potential Use as a Vaccine.

Zhou Y, Maharaj PD, Mallajosyula JK, McCormick AA, Kearney CM.

Mol Biotechnol. 2014 Nov 29. [Epub ahead of print]

PMID: 25432792 [PubMed - as supplied by publisher]

Related citations

Select item 25432588 248.

Factors Associated With Missed Opportunities for Influenza Vaccination: Review of Medical Records in a Diverse Sample of Primary Care Clinics, San Diego County, 2010- 2011.

Djibo DA, Peddecord KM, Wang W, Ralston K, Sawyer MH.

J Prim Care Community Health. 2014 Nov 27. pii: 2150131914559541. [Epub ahead of print]

PMID: 25432588 [PubMed - as supplied by publisher]

Related citations

Select item 25432510 249.

Vaccines, emerging viruses, and how to avoid disaster.

Rappuoli R.

BMC Biol. 2014 Nov 29;12(1):100. doi: 10.1186/s12915-014-0100-6.

PMID: 25432510 [PubMed - in process] Free PMC Article

Related citations

Select item 25432216 250.

85

Effect of inclusion of hepatitis B vaccine in childhood immunization program in India: a retrospective cohort study.

Aggarwal R, Babu JJ, Hemalatha R, Reddy AV, Sharma D, Kumar T.

Indian Pediatr. 2014 Nov 8;51(11):875-9.

PMID: 25432216 [PubMed - in process]

Related citations

Select item 25432214 251.

Utility of hepatitis B vaccination in India.

Kumar R, Puliyel J.

Indian Pediatr. 2014 Nov 8;51(11):870-2. No abstract available.

PMID: 25432214 [PubMed - in process]

Related citations

Select item 25432149 252.

HPV Vaccine Awareness, Barriers, Intentions, and Uptake in Latina Women.

Lechuga J, Vera-Cala L, Martinez-Donate A.

J Immigr Minor Health. 2014 Nov 29. [Epub ahead of print]

PMID: 25432149 [PubMed - as supplied by publisher]

Related citations

Select item 25431533 253.

A community-based intervention in middle schools to improve HPV vaccination and cervical cancer screening in Japan.

Ito T, Takenoshita R, Narumoto K, Plegue M, Sen A, Crabtree BF, Fetters MD.

Asia Pac Fam Med. 2014 Nov 18;13(1):13. eCollection 2014.

PMID: 86

25431533 [PubMed - as supplied by publisher] Free PMC Article

Related citations

Select item 25431096 254.

Vaccine therapies in malignant glioma.

Oh T, Sayegh ET, Fakurnejad S, Oyon D, Lamano JB, DiDomenico JD, Bloch O, Parsa AT.

Curr Neurol Neurosci Rep. 2015 Jan;15(1):508. doi: 10.1007/s11910-014-0508-y.

PMID: 25431096 [PubMed - in process]

Related citations

Select item 25431010 255.

An invasive and low virulent Edwardsiella tarda esrB mutant promising as live attenuated vaccine in aquaculture.

Yang W, Wang L, Zhang L, Qu J, Wang Q, Zhang Y.

Appl Microbiol Biotechnol. 2014 Nov 29. [Epub ahead of print]

PMID: 25431010 [PubMed - as supplied by publisher]

Related citations

Select item 25430610 256.

Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine.

Drescher KM, von Herrath M, Tracy S.

Rev Med Virol. 2014 Nov 27. doi: 10.1002/rmv.1815. [Epub ahead of print]

PMID: 25430610 [PubMed - as supplied by publisher]

Related citations

87

AMEDEO - Vaccines Publicaciones (01 - 12 - 2014): 29 artículos nuevos.

Vacunas meningococo (Neisseria meningitidis)

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

Vacunas neumococo (Streptococcus pneumoniae)

Vacunas fiebre tifoidea (Salmonella typhi)

Vacuna tuberculosis (Mycobacterium tuberculosis)

Vacuna tosferina (Bordetella pertussis)

Vacunas halal

Adyuvantes

Vacunas, otras

1. WOO EJ. Allergic reactions after egg-free recombinant influenza vaccine: reports to the US Reporting System. Clin Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=25428412&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25428412

2. MUNOZ FM, Weisman LE, Read JS, Siberry G, et al. Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy. Clin Infect Dis. 2014;59 Suppl 7:S415-27. PubMed: www.amedeo.com/p2.php?id=25425720&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25425720

3. GRUBER MF. Global and national initiatives to facilitate studies of vaccines in pregnant women. Clin Infect Dis. 2014;59 Suppl 7:S395-9. PubMed: www.amedeo.com/p2.php?id=25425717&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25425717

4. MORRISON VA, Johnson GR, Schmader KE, Levin MJ, et al. Long-Term Persistence of Efficacy. 88

Clin Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=25416754&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25416754

5. WHITLEY RJ. Waning Efficacy of the Herpes Zoster Vaccine: a Commentary. Clin Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=25416752&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25416752

6. FEENSTRA F, van Gennip RG, Maris-Veldhuis M, Verheij E, et al. Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge. J Gen Virol. 2014;95. PubMed: www.amedeo.com/p2.php?id=24914064&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24914064

7. BURGERS WA, Ginbot Z, Shen YJ, Chege GK, et al. The novel capripoxvirus vector lumpy skin disease virus efficiently boosts modified vaccinia Ankara human immunodeficiency virus responses in rhesus macaques. J Gen Virol. 2014;95. PubMed: www.amedeo.com/p2.php?id=24866849&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24866849

8. MOHN KG, Bredholt G, Brokstad KA, Pathirana RD, et al. The Longevity of B & T cell responses after live attenuated influenza vaccination in children. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=25425696&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25425696

9. SCHILLER JT, Lowy DR. Raising Expectations For Subunit Vaccine. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=25420478&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25420478

10. OHMIT SE, Petrie JG, Malosh RE, Fry AM, et al. Influenza Vaccine Effectiveness in Households with Children during the 2012-2013 Season: Assessments of Prior Vaccination and Serologic Susceptibility. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=25416812&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25416812

89

11. NEUZIL KM. How can we solve the enigma of influenza vaccine-induced protection? J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=25416811&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/25416811

12. CHAUDHRI G, Tahiliani V, Eldi P, Karupiah G, et al. Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses. J Virol. 2014 Nov 26. pii: JVI.02572. PubMed: www.amedeo.com/p2.php?id=25428875&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25428875

13. BAUSCH DG. One Step Closer to an Ebola Virus Vaccine. N Engl J Med. 2014. PubMed: www.amedeo.com/p2.php?id=25426836&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25426836

14. LEDGERWOOD JE, DeZure AD, Stanley DA, Novik L, et al. Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report. N Engl J Med. 2014. PubMed: www.amedeo.com/p2.php?id=25426834&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25426834

15. FONVILLE JM, Wilks SH, James SL, Fox A, et al. Antibody landscapes after influenza virus infection or vaccination. Science. 2014;346:996-1000. PubMed: www.amedeo.com/p2.php?id=25414313&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/25414313

16. COLEMAN CM, Liu YV, Mu H, Taylor JK, et al. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 2014;32:3169-74. PubMed: www.amedeo.com/p2.php?id=24736006&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24736006

17. KUMAR P, Ayalew LE, Godson DL, Gaba A, et al. Mucosal immunization of calves with recombinant bovine adenovirus-3 coexpressing truncated form of bovine herpesvirus-1 gD and bovine IL-6. Vaccine. 2014;32:3300-6. PubMed: www.amedeo.com/p2.php?id=24731813&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24731813

90

18. BOUKHEBZA H, Dubois C, Koerper V, Evlachev A, et al. Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naive and tolerant mouse models. Vaccine. 2014 Apr 10. pii: S0264-410X(14)00480. PubMed: www.amedeo.com/p2.php?id=24726690&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24726690

19. MISHRA S, Losikoff PT, Self AA, Terry F, et al. Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naive human T cells. Vaccine. 2014 Apr 7. pii: S0264-410X(14)00474. PubMed: www.amedeo.com/p2.php?id=24721533&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24721533

20. LIU Q, Liu K, Xue C, Zhou J, et al. Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice. Vaccine. 2014 Apr 2. pii: S0264-410X(14)00427. PubMed: www.amedeo.com/p2.php?id=24704333&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24704333

21. UPPALAPATI SR, Kingston JJ, Murali HS, Batra HV, et al. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein. Vaccine. 2014;32:3075-81. PubMed: www.amedeo.com/p2.php?id=24699467&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24699467

22. GOMBOLD J, Karakasidis S, Niksa P, Podczasy J, et al. Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products. Vaccine. 2014;32:2916-26. PubMed: www.amedeo.com/p2.php?id=24681273&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24681273

23. TAKEI S, Omoto C, Kitagawa K, Morishita N, et al. Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice. Vaccine. 2014 Mar 20. pii: S0264-410X(14)00366. PubMed: www.amedeo.com/p2.php?id=24657718&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24657718

24. FONTANA D, Kratje R, Etcheverrigaray M, Prieto C, et al. Rabies virus-like particles expressed in HEK293 cells. Vaccine. 2014 Mar 11. pii: S0264-410X(14)00204.

91

PubMed: www.amedeo.com/p2.php?id=24631077&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24631077

25. ASTRAY RM, Ventini DC, Boldorini VL, Silva FG, et al. Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors. Vaccine. 2014 Mar 2. pii: S0264-410X(14)00202. PubMed: www.amedeo.com/p2.php?id=24598721&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24598721

26. PASTOR AR, Rodriguez-Limas WA, Contreras MA, Esquivel E, et al. The assembly conformation of rotavirus VP6 determines its protective efficacy against rotavirus challenge in mice. Vaccine. 2014;32:2874-7. PubMed: www.amedeo.com/p2.php?id=24583002&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24583002

27. ZHANG R, Han X, Chen Y, Mustafa R, et al. Attenuated Mycoplasma bovis strains provide protection against virulent infection in calves. Vaccine. 2014;32:3107-14. PubMed: www.amedeo.com/p2.php?id=24462404&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24462404

28. XUE C, Tian X, Li X, Zhou Z, et al. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon. Virus Res. 2014;183:67-74. PubMed: www.amedeo.com/p2.php?id=24518297&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24518297

29. ORTEGO J, de la Poza F, Marin-Lopez A. Interferon alpha/beta receptor knockout mice as a model to study bluetongue virus infection. Virus Res. 2014;182:35-42. PubMed: www.amedeo.com/p2.php?id=24100234&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24100234

PATENTES

United States Patent and Trademark Office (USPTO) 92

Estrategia de búsqueda “vaccine” en título y abstract

(ABST/vaccine AND ISD/20141123->20141205): 16 patentes recuperadas.

Vacunas neumococo (Streptococcus pneumoniae)

8 8,895,724 Multivalent pneumococcal polysaccharide-protein conjugate composition

13 8,895,024 Multivalent pneumococcal polysaccharide-protein conjugate composition

Vacunas, otras

PAT. Title NO.

1 8,900,816 Assay for anti-EGFRvIII antibodies

2 8,900,599 Conjugates of Plasmodium falciparum surface proteins as

malaria vaccines

3 8,900,598 Multicomponent or monocomponent vaccine to be used against Chagas disease, pharmaceutical compositions containing them,

procedure for the obtention of immunogen of said vaccines, and

nucleic acid used in said procedure

4 8,900,594 Oral recombinant Helicobacter pylori vaccine and preparing

method thereof

5 8,900,592 Protein constructs designed for targeting and lysis of cells

6 8,900,591 Vaccines comprising mutant GPCRs with increased

conformational stability relative to parent receptors

7 8,900,564 Vaccine composition comprising an antigen and a peptide having

adjuvant properties

8 8,895,724 Multivalent pneumococcal polysaccharide-protein conjugate

composition

9 8,895,577 Compounds and compositions as TLR activity modulators

10 8,895,514 Composition of tumor-associated peptides and related anti- for the treatment of glioblastoma (GBM) and

other cancers

11 8,895,501 Eye-drop vaccine containing copolymer 1 for therapeutic

immunization

12 8,895,237 Enhancing of hepatitis B virus vaccine and its gene

13 8,895,024 Multivalent pneumococcal polysaccharide-protein conjugate

composition

14 8,895,017 HER-2 peptides and vaccines

15 8,895,015 Norovirus capsid and rotavirus VP6 protein for use as combined

vaccine

93

16 8,895,014 Bioconjugates made from recombinant N-glycosylated proteins

from procaryotic cells

European Patent Office (EPO)

Acumulado entre el 23 de noviembre y el 5 de diciembre de 2014: 8 patentes recuperadas

Vacunas, otras

1. Cellular vaccine and method of inducing an immune response in a subject

Applicant: IPC: CPC: Priority Inventor: Publication info: ADELAIDE RES A61K31/711 date: A61K2300/00 GOWANS ERIC & A61K39/00 AU2013262426 (A1) A61K31/711 2012- JAMES INNOVATION A61K39/21 2014-11-27 (+7) 05-16 PTY (+4)

2. KOI HERPESVIRUS VACCINE

Applicant: CPC: Priority Inventor: UNIV LIEGE IPC: Publication info: A61K2039/5254 date: FACULTY OF VANDERPLASSCHEN A61K2039/5256 A61K39/245 US2014348875 (A1) VETERINARY 2011- ALAIN [BE] A61K2039/552 C12N7/00 2014-11-27 MEDICINE 12-30 (+7) [BE]

3. PORCINE CIRCOVIRUS TYPE-2 (PCV2) SUBUNIT VACCINE

Inventor: CPC: IPC: Applicant: Priority KUO TSUN-YUNG Publication info: A61K39/12 C07K14/005 date: [TW] SBC VIRBAC C07K14/005 C07K14/21 US2014348864 (A1) CHEN HSU-CHUNG BIOTECH CO 2011- C07K14/01 C07K5/103 2014-11-27 GABRIEL [TW] LTD [TW] 12-06 (+7) (+1) (+2)

4. VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

CPC: IPC: Applicant: Priority Inventor: Publication info: A61K2039/5154 A61K31/192 date: IRX HADDEN JOHN W A61K2039/5158 A61K31/365 US2014348783 (A1) THERAPEUTICS 2000- [US] A61K2039/55522 A61K31/405 2014-11-27 INC [US] 10-27 (+24) (+13)

5. AUTOLOGOUS CANCER CELL VACCINE

CPC: Applicant: Priority Inventor: Publication info: A61K2039/5152 IPC: date: KREUTZ KREUTZ FERNANDO A61K2039/5158 EP2804626 (A1) FERNANDO A61K39/00 2012- THOME [BR] A61K2039/55 2014-11-26 THOME [BR] 01-20 (+2)

94

6. INFLUENZA C VIRUS AND VACCINE

Inventor: CPC: IPC: Priority SIMONSON RANDY Applicant: Publication info: A61K2039/5252 date: R [US] A61K39/145 NEWPORT LAB C07K14/005 EP2807184 (A1) COLLIN EMILY A A61P31/16 2012- INC [US] C12N2760/16321 2014-12-03 [US] C07K14/11 01-27 (+3) (+1)

7. METHOD FOR FORMULATING A VACCINE CONTAINING AT LEAST TWO ANTIGENS CAPABLE OF ADSORBING ONTO ALUMINIUM OXYHYDROXIDE

Inventor: CPC: IPC: Priority BERTAUX LANDRY Applicant: Publication info: A61K2039/55505 date: [FR] A61K39/295 SANOFI A61K2039/70 EP2804628 (A1) CHACORNAC A61P31/04 2012- PASTEUR [FR] A61K39/12 2014-11-26 ISABELLE [FR] A61P31/12 01-17 (+1) (+3)

8. VACCINE COMPOSITIONS FOR HIV PREVENTION AND TREATMENT

Applicant: INST NAT SANTÉ ET DE Inventor: CPC: IPC: LA RECH Priority Publication info: BOMSEL MORGANE MÉDICALE A61K2039/507 A61K39/395 date: [FR] INSERM [FR] A61K39/12 C07K14/16 EP2807181 (A1) 2012- TUDOR DANIELA UNIVERSITÉ C07K16/1063 C07K16/10 2014-12-03 01-2 [FR] PARIS (+9) (+1) DESCARTES [FR] (+2)

95

TABLAS DE CONTENIDO

Revista Vaccine

Tabla de Contenidos. Volume 32, Issue 52, Pages 7033 - 7184, (12 December, 2014)

Special Section: Vaccination Ethics Edited by Adrian M. Viens and Angus J. Dawson

Editorial Board/Aims and Scope Pages IFC

Meeting report

Considerations around the introduction of a in Bangladesh Pages 7033-7036 Christopher B. Nelson, Vittal Mogasale, Tajul Islam A. Bari, John D. Clemens

Commentaries

Seasonal and pandemic influenza vaccine: Demand, supply and vaccine availability Pages 7037-7039 Bruce G. Gellin, William K. Ampofo

Increasing engagement of clinicians in adult : Reflections on a decade and a half of research Pages 7040-7042 Richard K. Zimmerman

Short communication

Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain Pages 7043-7046 Ruth Gil-Prieto, Laura Garcia-Garcia, María San-Martin, Angel Gil-de-Miguel

Brief report

Monitoring coverage of fully immunized children

96

Pages 7047-7049 Asnakew Tsega, Fussum Daniel, Robert Steinglass

Reviews

The use of serosurveys following emergency vaccination, to recover the status of “foot-and-mouth disease free where vaccination is not practised” Review Article Pages 7050-7056 D.J. Paton, A.-E. Füssel, W. Vosloo, A. Dekker, K. De Clercq

Safety of immunization during pregnancy: A review of the evidence of selected inactivated and live attenuated vaccines Review Article Pages 7057-7064 Brigitte Keller-Stanislawski, Janet A. Englund, Gagandeep Kang, Punam Mangtani, Kathleen Neuzil, Hanna Nohynek, Robert Pless, Philipp Lambach, Patrick Zuber

Regular papers

Surveillance of congenital rubella syndrome (CRS) in tertiary care hospitals in Hanoi, Vietnam during a rubella epidemic Original Research Article Pages 7065-7069 Nguyen Van Bang, Nguyen Thi Van Anh, Vu Thi Tuong Van, Trieu Thi Hong Thai, Nguyen Van Thuong, Gulam Khandaker, Elizabeth Elliott

Variation in exemptions to school immunization requirements among New York State private and public schools Original Research Article Pages 7070-7076 Yun-Kuang Lai, Jessica Nadeau, Louise-Anne McNutt, Jana Shaw

Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study Original Research Article Pages 7077-7084 Anna Lundgren, Louis Bourgeois, Nils Carlin, John Clements, Björn Gustafsson, Marianne Hartford, Jan Holmgren, Max Petzold, Richard Walker, Ann-Mari Svennerholm

Factors associated with seasonal influenza immunization among church-going older African Americans Original Research Article Pages 7085-7090 Sahithi Boggavarapu, Kevin M. Sullivan, Jay T. Schamel, Paula M. Frew

Rational design of medium supplementation strategy for improved influenza viruses production based on analyzing nutritional requirements of MDCK Cells

97

Original Research Article Pages 7091-7097 Ding Huang, Kang Xia-Hou, Xu-Ping Liu, Liang Zhao, Li Fan, Zhaoyang Ye, Wen-Song Tan, Jian Luo, Ze Chen

A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human Original Research Article Pages 7098-7107 Jaap T. van Dissel, Simone A. Joosten, Søren T. Hoff, Darius Soonawala, Corine Prins, David A. Hokey, Dawn M. O’Dee, Andrew Graves, Birgit Thierry-Carstensen, Lars V. Andreasen, Morten Ruhwald, Adriëtte W. de Visser, Else Marie Agger, Tom H.M. Ottenhoff, Ingrid Kromann, Peter Andersen

VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA Original Research Article Pages 7108-7114 Femke Feenstra, Mieke Maris-Veldhuis, Franz J. Daus, Mirriam G.J. Tacken, Rob J.M. Moormann, René G.P. van Gennip, Piet A. van Rijn

Evaluation of cells and biological reagents for adventitious agents using degenerate primer PCR and massively parallel sequencing Original Research Article Pages 7115-7121 Shasta D. McClenahan, Christine Uhlenhaut, Philip R. Krause

Determinants of influenza vaccination coverage rates among primary care patients in Krakow, Poland and the surrounding region Original Research Article Pages 7122-7127 Katarzyna Nessler, Anna Krztoń-Królewiecka, Teresa Chmielowiec, Dorota Jarczewska, Adam Windak

Qualitative motivators and barriers to pandemic vs. seasonal influenza vaccination among healthcare workers: A content analysis Original Research Article Pages 7128-7134 Chatura Prematunge, Kimberly Corace, Anne McCarthy, Rama C. Nair, Virginia Roth, Kathryn N. Suh, Gary Garber

Number needed to vaccinate to prevent hospitalizations of pregnant women due to inter-pandemic influenza in Sweden, 2003–2009 Original Research Article Pages 7135-7140 Hanna Merk, Gunnar Nylén, Sharon Kühlmann-Berenzon, Annika Linde

Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children Original Research Article Pages 7141-7147 Rebecca C. Brady, Wilson Hu, Vonda G. Houchin, Frank S. Eder, Kenneth C. Jackson, Gunter

98

F. Hartel, Daphne C. Sawlwin, Frank R. Albano, Michael Greenberg

Seasonal variation in rates of emergency room visits and acute admissions following recommended infant vaccinations in Ontario, Canada: A self-controlled case series analysis Original Research Article Pages 7148-7153 Steven Hawken, Beth K. Potter, Eric I. Benchimol, Julian Little, Robin Ducharme, Kumanan Wilson

Analysis of safety data in children after receiving two doses of ProQuad® (MMRV) Original Research Article Pages 7154-7160 Stephanie O. Klopfer, Jon E. Stek, Maria Petrecz, Keith S. Reisinger, Steven B. Black, Michelle G. Goveia, Ouzama Nicholson, Julie L. Gardner, Anthony D. Grosso, Michelle L. Brown, Barbara J. Kuter, Florian P. Schödel

Special Section: Vaccination Ethics

Vaccination ethics Pages 7161-7162 A.M. Viens, Angus Dawson

What is the responsibility of national government with respect to vaccination? Original Research Article Pages 7163-7166 Marcel F. Verweij, Hans Houweling

How high is a high risk? Prioritising high-risk individuals in an influenza pandemic Original Research Article Pages 7167-7170 Jasper Littmann

Ethical considerations in post-market-approval monitoring and regulation of vaccines Original Research Article Pages 7171-7174 Alison Thompson, Ana Komparic, Maxwell J. Smith

Varicella-zoster virus vaccination under the exogenous boosting hypothesis: Two ethical perspectives Original Research Article Pages 7175-7178 Jeroen Luyten, Benson Ogunjimi, Philippe Beutels

The ethics of disease eradication Original Research Article Pages 7179-7183

99

James Wilson

Tabla de Contenidos. Volume 33, Issue 1, Pages 1 - 276, (1 January, 2015)

Editorial

Recommendations for strengthening NITAG policies in developed countries Pages 1-2 G.W. Ricciardi, M. Toumi, G. Poland

Comparison of NITAG policies and working processes in selected developed countries Original Research Article Pages 3-11 G.W. Ricciardi, M. Toumi, C. Weil-Olivier, E.J. Ruitenberg, D. Dankó, G. Duru, J. Picazo, Y. Zöllner, G. Poland, M. Drummond

Letters to the Editor

Reply: Cochrane rearranged Pages 12 Michael T. Osterholm, Nicholas S. Kelley, Edward A. Belongia, Lisa A. Jackson, Michael L. Jackson

Reply: Letter to the Editor, Cochrane Rearranged Pages 13-14 W.E.P. Beyer, J. McElhaney, D.J. Smith, A.S. Monto, J.S. Nguyen-Van-Tam, A.D.M.E. Osterhaus

Hepatitis B vaccine response among infants born to hepatitis B surface antigen- positive women Pages 15-16 Terence T. Lao, K.L. Cheung, Vincent Wong

Reply to response to Limitations of the study “Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults” Pages 17 Mitja Kos, Igor Locatelli

Short communication

On birth single dose live attenuated OPV and BCG vaccination induces gut cathelicidin LL37 responses at 6 week of age: A natural experiment

100

Pages 18-21 Md. Jahangir Alam, Md. Mamunur Rashid, Yearul Kabir, Rubhana Raqib, Shaikh Meshbahuddin Ahmad

Brief report

Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008–2014 Pages 22-24 Loren Rodgers, Laura J. Pabst, Sandra S. Chaves

Reviews

A perspective on the use of Pleurotus for the development of convenient fungi- made oral subunit vaccines Review Article Pages 25-33 Ana S. Pérez-Martínez, Sergio A. Acevedo-Padilla, Martha Bibbins-Martínez, Jenifer Galván- Alonso, Sergio Rosales-Mendoza

Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries Review Article Pages 34-51 Leonardo Simonella, Karen Canfell

Twenty-five years of the WHO vaccines prequalification programme (1987–2012): Lessons learned and future perspectives Review Article Pages 52-61 Nora Dellepiane, David Wood

Brighton Collaboration papers

Live virus vaccines based on a backbone: Standardized template with key considerations for a risk/benefit assessment Original Research Article Pages 62-72 Thomas P. Monath, Stephen J. Seligman, James S. Robertson, Bruno Guy, Edward B. Hayes, Richard C. Condit, Jean Louis Excler, Lisa Marie Mac, Baevin Carbery, Robert T. Chen, The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) Pages 73-75 Robert T. Chen, Baevin Carbery, Lisa Mac, Kenneth I. Berns, Louisa Chapman, Richard C. Condit, Jean-Louis Excler, Marc Gurwith, Michael Hendry, Arifa S. Khan, Najwa Khuri-Bulos,

101

Bettina Klug, James S. Robertson, Stephen J. Seligman, Rebecca Sheets, Anna-Lise Williamson, for the V3SWG

WHO Report

Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013— Recommendations Pages 76-77 WHO

Regular papers

Particle quantification of influenza viruses by high performance liquid chromatography Original Research Article Pages 78-84 Julia Transfiguracion, Aziza P. Manceur, Emma Petiot, Christine M. Thompson, Amine A. Kamen

BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells Original Research Article Pages 85-91 Andrea Cruz, Egídio Torrado, Jenny Carmona, Alexandra G. Fraga, Patrício Costa, Fernando Rodrigues, Rui Appelberg, Margarida Correia-Neves, Andrea M. Cooper, Margarida Saraiva, Jorge Pedrosa, António G. Castro

Development of a subunit vaccine containing recombinant Riemerella anatipestifer outer membrane protein A and CpG ODN adjuvant Original Research Article Pages 92-99 Chun-Yen Chu, Chia-Hui Liu, Jhong-Jie Liou, Jai-Wei Lee, Li-Ting Cheng

Development of a Salmonella cross-protective vaccine for food animal production systems Original Research Article Pages 100-107 Douglas M. Heithoff, John K. House, Peter C. Thomson, Michael J. Mahan

Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine Original Research Article Pages 108-116 Donald M. Carter, Chalise E. Bloom, Greg A. Kirchenbaum, Vadim Tsvetnitsky, Irina Isakova- Sivak, Larisa Rudenko, Ted M. Ross

The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae Original Research Article

102

Pages 117-125 Kuniaki Nerome, Shigeo Sugita, Kazumichi Kuroda, Toshiharu Hirose, Sayaka Matsuda, Kei Majima, Kazunori Kawasaki, Toshikatsu Shibata, Okti Nadia Poetri, Retno D. Soejoedono, Ni L.P. Ika Mayasari, Srihadi Agungpriyono, Reiko Nerome

Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice Original Research Article Pages 126-132 Steven C. Derrick, Amy Yang, Marcela Parra, Kristopher Kolibab, Sheldon L. Morris

Canine zona pellucida glycoprotein-3: Up-scaled production, immunization strategy and its outcome on fertility Original Research Article Pages 133-140 Abhinav Shrestha, Sudeepa Srichandan, Vidisha Minhas, Amulya Kumar Panda, Satish Kumar Gupta

An adenoviral vector expressing lipoprotein A, a major antigen of Mycoplasma mycoides subspecies mycoides, elicits robust immune responses in mice Original Research Article Pages 141-148 Marlène Carozza, Valérie Rodrigues, Yves Unterfinger, Sandra Galea, Muriel Coulpier, Bernard Klonjkowski, François Thiaucourt, Philippe Totté, Jennifer Richardson

CD4+ T-cells, γδ T-cells and B-cells are associated with lack of vaccine protection in Mycobacterium avium subspecies paratuberculosis infection Original Research Article Pages 149-155 Kumudika de Silva, Karren M. Plain, Douglas J. Begg, Auriol C. Purdie, Richard J. Whittington

Vaccination of pigs with attenuated Lawsonia intracellularis induced acute phase protein responses and primed cell-mediated immunity without reduction in bacterial shedding after challenge Original Research Article Pages 156-162 Ulla Riber, Peter M.H. Heegaard, Henriette Cordes, Marie Ståhl, Tim Kåre Jensen, Gregers Jungersen

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009–2010 seasonal trivalent influenza vaccinations Original Research Article Pages 163-173 Sharon E. Frey, David I. Bernstein, Rebecca C. Brady, Wendy A. Keitel, Hana El Sahly, Nadine Georges Rouphael, Mark J. Mulligan, Robert L. Atmar, Srilatha Edupuganti, Shital M. Patel, Michelle Dickey, Irene Graham, Edwin L. Anderson, Diana L. Noah, Heather Hill, Mark Wolff, Robert B. Belshe

Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age Original Research Article

103

Pages 174-181 Markus Knuf, Geert Leroux-Roels, Hans. C. Rümke, Katia Abarca, Luis Rivera, Maria Lattanzi, Paola Pedotti, Ashwani Arora, Dorothee Kieninger-Baum, Giovanni Della Cioppa

Seasonal influenza vaccination rates and reasons for non-vaccination in children with gastrointestinal disorders Original Research Article Pages 182-186 Noam Peleg, Noam Zevit, Raanan Shamir, Gabriel Chodick, Itzhak Levy

Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean Original Research Article Pages 187-192 A.M. Ropero-Álvarez, A. Whittembury, P. Bravo-Alcántara, H.J. Kurtis, M.C. Danovaro- Holliday, M. Velandia-González

Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates Original Research Article Pages 193-200 Andrew J. Broadbent, Celia P. Santos, Myeisha Paskel, Yumiko Matsuoka, Janine Lu, Zhongying Chen, Hong Jin, Kanta Subbarao

Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program Original Research Article Pages 201-208 Sarah L. Osborne, Sepehr N. Tabrizi, Julia M.L. Brotherton, Alyssa M. Cornall, John D. Wark, C. David Wrede, Yasmin Jayasinghe, Dorota M. Gertig, Marian K. Pitts, Suzanne M. Garland, VACCINE Study group

The effect of bacille Calmette-Guérin vaccination at birth on immune response in China Original Research Article Pages 209-213 Yu Pang, Wanli Kang, Aihua Zhao, Guan Liu, Weixin Du, Miao Xu, Guozhi Wang, Yanlin Zhao, Suhua Zheng

Why German farmers have their animals vaccinated against Bluetongue virus serotype 8: Results of a questionnaire survey Original Research Article Pages 214-221 J. Gethmann, V. Zilow, C. Probst, A.R.W. Elbers, F.J. Conraths

Impact of a combined pediatric and adult pneumococcal immunization program on adult pneumonia incidence and mortality in Nicaragua Original Research Article Pages 222-227 Sylvia Becker-Dreps, Erick Amaya, Lan Liu, Julio Rocha, Rafaela Briceño, Gilberto Moreno, Jorge Alemán, Michael G. Hudgens, Christopher W. Woods, David J. Weber

104

What predicts postpartum pertussis booster vaccination? A controlled intervention trial Original Research Article Pages 228-236 Elizabeth Helen Hayles, Spring Chenoa Cooper, Nicholas Wood, John Sinn, S. Rachel Skinner

Measles–mumps–rubella vaccination and respiratory syncytial virus-associated hospital contact Original Research Article Pages 237-245 Signe Sørup, Christine Stabell Benn, Lone Graff Stensballe, Peter Aaby, Henrik Ravn

Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season Original Research Article Pages 246-251 Edward A. Belongia, Maria E. Sundaram, David L. McClure, Jennifer K. Meece, Jill Ferdinands, Jeffrey J. VanWormer

Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutant Original Research Article Pages 252-259 Bei Wang, Su Wang, Richard R. Rustandi, Feng Wang, Christopher D. Mensch, Laura Hong, Adam Kristopeit, Susan Secore, Geethanjali Dornadula, Anthony Kanavage, Jon H. Heinrichs, Henryk Mach, Jeffrey T. Blue, David S. Thiriot

Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice Original Research Article Pages 260-267 Rhonda KuoLee, Greg Harris, Hongbin Yan, H. Howard Xu, Wayne J. Conlan, Girishchandra B. Patel, Wangxue Chen

Evaluation of serogroup C and ACWY programs: Projected impact on disease burden according to a stochastic two-strain dynamic model Original Research Article Pages 268-275 David M. Vickers, Andrea M. Anonychuk, Philippe De Wals, Nadia Demarteau, Chris T. Bauch

105